Product Detail Manual EP

User Manual: EP

Open the PDF directly: View PDF .
Page Count: 41

PCT Applicant’s Guide – National Phase – National Chapter – EP Page 1

(1 March 2018)

EUROPEAN PATENT OFFICE (EPO)

DESIGNATED (OR ELECTED) OFFICE

CONTENTS

THE ENTRY INTO THE NATIONAL PHASE — SUMMARY

THE PROCEDURE IN THE NATIONAL PHASE

ANNEXES

Fees ............................................................... Annex EP.I

Entry into the European phase (EPO as designated or elected Office)

(EPO Form 1200) ................................................... Annex EP.II

Designation of inventor (EPO Form 1002) .................................. Annex EP.III

Authorisation (EPO Form 1003) .......................................... Annex EP.IV

General Authorisation (EPO Form 1004) ................................... Annex EP.V

List of abbreviations:

EPC: Convention on the Grant of European Patents (European Patent Convention)

Rfees: Rules relating to Fees (of the European Patent Office)

OJ EPO: Official Journal of the European Patent Office

Euro-PCT Guide (www.epo.org/applying/international.html)

PCT Applicant’s Guide – National Phase – National Chapter – EP

Page 3

(1 March 2018)

SUMMARY

Designated

(or elected) Office

SUMMARY

EUROPEAN PATENT OFFICE (EPO)

Summary of requirements for entry into the national phase

Time limits applicable for entry into the

national phase:

Under PCT Article 22(3): 31 months from the priority date

Under PCT Article 39(1)(b): 31 months from the priority date

Translation of international application

required into:

English, French or German

Required contents of the translation for

entry into the national phase:

Under PCT Article 22: Description, claims (if amended, both as

originally filed and as amended, if the applicant wishes the

amendments to form the basis for the proceedings, together with any

statement under PCT Article 191), any text matter of drawings,

abstract

Under PCT Article 39(1): Description, claims, any text matter of

drawings (if any of those parts has been amended, both as originally

filed and as amended by the annexes to the international preliminary

report on patentability (Chapter II) and claims amended under PCT

Article 19, if the applicant wishes these amendments to form the

basis for the proceedings, together with any statement under PCT

Article 191), abstract

Is a copy of the international application

required?

National fee:

Currency: Euro (EUR)

Filing fee:2

– where the form for entry into the European

phase (EPO Form 1200) is filed online: EUR 120

– where the form for entry into the European

phase (EPO Form 1200) is not filed online: EUR 210

Additional fee for pages in excess of 35:

for the 36th and each subsequent page EUR 15

Designation fee for one or more EPO

Contracting States designated:3 EUR 585

Extension fee for each extension State

(extension of the European patent to Bosnia

and Herzegovina or Montenegro):3 EUR 102

Fee for validation of the European patent in:

– Cambodia:3, 4 EUR 180

– Morocco:3, 5 EUR 240

– Republic of Moldova:3, 6 EUR 200

– Tunisia:3, 7 EUR 180

[Continued on next page]

______________

Where the applicant furnishes only one translation of the international application, or any part of it, either as originally filed or as

amended, the Office will invite the applicant to furnish the missing translation within a reasonable time limit. If the translation of

the amended part or of the international application as initially filed is missing and is not furnished, the international application

will be considered withdrawn.

Must be paid within 31 months from the priority date. For claims fees see also paragraph EP.08 of National Chapter EP.

The designation, extension and validation fees are payable within 31 months from the priority date.

Validation of the European patent in Cambodia is only available for international applications filed on or after 1 March 2018.

See OJ EPO 2/2018, A16.

Validation of the European patent in Morocco is only available for international applications filed on or after 1 March 2015.

See OJ EPO 2/2015, A18-A20.

Validation of the European patent in the Republic of Moldova is only available for international applications filed on or after

1 November 2015. See OJ EPO 10/2015, A85.

Validation of the European patent in Tunisia is only available for international applications filed on or after 1 December 2017.

See OJ EPO 10/2017, A85.

Page 4

PCT Applicant’s Guide – National Phase – National Chapter – EP

(1 March 2018)

SUMMARY

Designated

(or elected) Office

SUMMARY

EUROPEAN PATENT OFFICE (EPO)

[Continued]

National fee (cont’d):

Claims fee:8

– for the 16th and each subsequent claim

up to the limit of 50: EUR 235

– for the 51st and each subsequent claim: EUR 585

Search fee:8

– for (international) applications filed

before 1 July 2005: EUR 885

– for (international) applications filed

on or after 1 July 2005: EUR 1,300

Fee for further processing:

– in the event of late payment

of a fee: 50% of the relevant fee

– other cases: EUR 255

Fee for late furnishing of a sequence listing:EUR 230

Examination fee:9

– for (international) applications filed

before 1 July 2005: EUR 1,825

– for (international) applications filed

on or after 1 July 2005 for which no

supplementary European search

report is drawn up: EUR 1,825

– for all other (international) applications

filed on or after 1 July 2005: EUR 1,635

Renewal fee for the third year:10 EUR 470

Exemptions, reductions or refunds of

fees:11

No search fee is payable

– where the international search report has been established by the

EPO;

– where the international application has been filed before

1 July 2005 and the international search report has been

established by the Austrian Patent Office, the Spanish Patent and

Trademark Office or the Swedish Patent and Registration Office;

– where the international application has been filed between

1 April 2005 and 30 June 2005 and the international search

report has been established by the Finnish Patent and

Registration Office (PRH).

The search fee is reduced

– by 20% (international applications filed before 1 July 2005) or

– by EUR 190 (international applications filed on or after

1 July 2005)

where the international search report has been established by the

Australian Patent Office, the Federal Service for Intellectual

Property (Rospatent) (Russian Federation), the Japan Patent Office,

the Korean Intellectual Property Office, the State Intellectual

Property Office of the People’s Republic of China or the United

States Patent and Trademark Office.

[Continued on next page]

______________

See footnote 2.

A request for examination must be made and the examination fee must be paid within the time limit applicable under PCT

Article 22 or 39(1) and EPC Rule 159(1).

This fee is due before the expiration of the month containing the second anniversary (24 months) of the international filing date; it

is due within 31 months from the priority date if that 31-month time limit expires later.

See OJ EPO 3/2006, pages 189 and 192, 12/2007, page 692, 1/2008, page 12 and 2/2009, page 96 et seq., 5/2010, page 338 et seq.

and 12/2011, page 616 et seq.

PCT Applicant’s Guide – National Phase – National Chapter – EP

Page 5

(1 March 2018)

SUMMARY

Designated

(or elected) Office

SUMMARY

EUROPEAN PATENT OFFICE (EPO)

[Continued]

Exemptions, reductions or refunds of

fees (cont’d):12

The search fee is reduced

– by EUR 1,11013 for international applications for which the

international search report or a supplementary international search

report has been established by the Austrian Patent Office, or in

accordance with the Protocol on Centralisation by the Finnish Patent

and Registration Office (PRH), the Nordic Patent Institute, the

Spanish Patent and Trademark Office, the Swedish Patent and

Registration Office, the Turkish Patent and Trademark Office

(Turkpatent) or the Visegrad Patent Institute.

The search fee is refunded fully or in part where the supplementary

European search report is based on an earlier search report prepared

by the Office.

The examination fee is reduced by 50% where the international

preliminary report on patentability (Chapter II) has been established

by the EPO.14

Furthermore, in certain cases the examination fee is reduced by 30%

for language reasons.14

Special requirements of the Office

(PCT Rule 51bis):15

Name and address of the inventor if they have not been furnished in

the “Request” part of the international application or in a declaration

in accordance with PCT Rule 4.17(i)

Address, nationality and residence of the applicant if they have not

been furnished in the “Request” part of the international application

Appointment of an agent if the applicant has neither a residence nor

his principal place of business within the territory of one of the

Contracting States of the European Patent Convention

Furnishing, where applicable, of a nucleotide and/or amino acid

sequence listing in electronic form

Who can act as agent?

Any professional representative entered on the relevant list

maintained by the EPO (the directory of professional representatives

can be consulted on the EPO website)16

Any legal practitioner qualified to practice in patent matters in one

of the States party to the European Patent Convention and who has

his place of business in that State

Does the Office accept requests for

restoration of the right of priority

(PCT Rule 49ter.2)?

Yes, the Office applies the “due care” criterion to such requests

______________

See footnote 11 and OJ EPO 3/2013, page 153 et seq.

See the Decisions of the EPO’s Administrative Council dated 16 December 2015 (CA/D 8/15) and 28 June 2017 (CA/D 9/17).

See also paragraph EP.14 of National Chapter EP and OJ EPO 2/2014, A23.

If not already complied with within the time limit applicable under PCT Article 22 or 39(1) (31 months from the priority date), the

Office will invite the applicant to comply with the requirement within two months. In respect of nucleotide and/or amino acid

sequence listings, see also OJ EPO 6/2011, page 372 and OJ EPO 11/2013, page 542.

See www.epo.org/applying/online-services/representatives.html

PCT Applicant’s Guide – National Phase – National Chapter – EP Page 7

(1 March 2018)

THE PROCEDURE IN THE NATIONAL PHASE

Detailed information on the procedure before the EPO as designated Office and as elected

Office can also be found in the “Euro-PCT Guide” (“PCT procedure before the EPO”), to be

ordered from the EPO Customer Service Centre and available on the EPO website

www.epo.org/applying/international.html

Euro-PCT Guide, 420

et seq.

EP.01 FORM FOR ENTERING THE NATIONAL PHASE. The EPO has available a

special form for entering the national phase (EPO Form 1200–see Annex EP.III).

The EPO strongly recommends that applicants use the latest version of this form which

contains detailed explanatory notes. The form is also available on the EPO’s website:

www.epo.org/applying/forms-fees/forms.html. The form may be filed electronically (see

OJ EPO 2015, A91). It is also possible to file EPO Form 1200 online via the EPO case

management system and the EPO web-form filing service (see OJ EPO 2014, A98 and

OJ EPO 2015, A27).

EPC Art. 14

153(4)

Euro-PCT Guide, 418

419

EP.02 LANGUAGE OF PROCEEDINGS. The language of proceedings is one of the

EPO official languages (English, French or German). If the international application has been

published in one of those languages, this language is the language of proceedings; if not, the

language of the translation which must be submitted upon entry into the European phase will be

the language of the proceedings. The language of proceedings cannot be changed

subsequently.

EPC Rule 3(1), 3(2)

Euro-PCT Guide, 512

In written proceedings, the applicant may use any official language of the EPO. However,

amendments (see paragraph EP.18) to the application itself must be filed in the language of the

proceedings.

PCT Art. 19(1)

PCT Rules 49.3

70.16

74(1)

Euro-PCT Guide, 517-

521

EP.03 TRANSLATION OF THE APPLICATION. In addition to those elements of the

translation which must be furnished within the time limit of 31 months from the priority date

(the description, the claims and any text in the drawings as originally filed and the abstract as

published), the following elements should also be included:

if the EPO acts as designated Office:

– any amendments made to the claims under PCT Article 19 in the form of a

translation of the complete set of claims furnished in replacement of all claims originally filed

only if the applicant wishes such amendments to form the basis of further proceedings. The

amendments must be submitted together with, if submitted to the International Bureau, the

statement under PCT Article 19(1) explaining the amendments and, in every case, the

accompanying letter under PCT Rule 46.5(b) in an official language of the EPO. If a

translation of the complete set of claims submitted under PCT Article 19 is not furnished or not

accompanied by a translation of, if submitted to the International Bureau, the statement under

PCT Article 19(1) and, in every case, the accompanying letter under PCT Rule 46.5(b), the

amendments under PCT Article 19 will be disregarded for the further proceedings. If only the

statement under PCT Article 19(1) is not available in an official language, only that document

will be disregarded;

– any indication under PCT Rule 13bis.3 and 13bis.4, i.e., separately furnished

reference to deposited biological material;

– any nucleotide and amino acid sequence listing under PCT Rule 5.2(a), unless the

text in the sequence listing is available to the EPO in English;

– any request for rectification referred to in PCT Rule 91.3(d) as published in

accordance with PCT Rule 48.2(a)(vii).

if the EPO acts as elected Office:

– translation of any annexes to the international preliminary report on patentability

(Chapter II), i.e. regardless of whether protection is sought for the same version of the

application documents as was the subject of that report. If any amendments under PCT Article

19 are annexed to the IPRP (Chapter II), a translation of those amendments must also always be

filed.

Page 8 PCT Applicant’s Guide – National Phase – National Chapter – EP

(1 March 2018)

If the applicant wishes the amendments to the claims made before the IB under PCT Article 19

to form the basis of the procedure before the EPO as elected Office, and these amendments are

not annexed to the IPRP (Chapter II) (for instance because they were considered reversed by an

amendment under PCT Article 34), then these amendments must also be furnished in translated

form, as otherwise they will be disregarded for the further proceedings. Any statement under

PCT Article 19(1) and, in every case, the letter under Rule PCT 46.5(b) must also be furnished

in an official language of the EPO. If only the statement under PCT Article 19(1) is not

available in an official language, only that document will be disregarded.

If the translation of all annexes is not filed in due time, the applicant is invited to furnish the

missing translation within two months of notification of a communication. If the applicant fails

to comply, the Euro-PCT application is deemed to be withdrawn. The applicant may request

further processing (or re-establishment of rights under PCT Rule 49.6 if the application is

deemed withdrawn because the translation was not filed in due time. However, the fee is

higher and stricter requirements apply. Therefore, this remedy has only advantages if the

period for requesting further processing has already expired).

EP.04 TRANSLATION (CORRECTION). Errors in the translation of the international

application can be corrected with reference to the text of the international application as filed

(see National Phase, paragraphs 6.002 and 6.003).

RFees Art. 5

EP.05 FEES (MANNER OF PAYMENT). The manner of payment of the fees indicated

in the Summary and in this Chapter is outlined in Annex EP.I. Payments via a deposit account

held with the EPO are only accepted if made online, i.e. in an electronically processable format

(XML), using, e.g. the electronic EPO filing forms or the Online Fee Payment in Online

services. This also applies to automatic debit orders. For more details, see Extract from the

Arrangements for deposit accounts (ADA) and their annexes in Annex EP.I and the

Supplementary publication 5 to OJ EPO 2017.

PCT Art. 22(1), 39(1)

EPC Art. 78(2)

EPC Rule 159(1)(c)

165

RFees Art. 2(1).1

OJ EPO 2009, 118

Euro-PCT Guide, 534-

536

661

EP.05a FILING FEE. Within the 31-month time limit the European filing fee must be paid.

This fee is composed of a basic fee and an additional fee which is due for the 36th and each

subsequent page of the application. The additional fee is referred to as the “page fee”. The

basic fee is reduced where EPO Form 1200 is filed online, via the EPO case management

system or the EPO web-form filing service. If the basic filing fee and/or, where applicable, the

page fee, is not paid in full in due time, the application will be deemed withdrawn. In addition,

the Euro-PCT application will not be considered as comprised in the state of the art under

EPC Article 54(3).

EPC Rule 38(2)

RFees Art. 2(1).1a

OJ EPO 2009, 338

Euro-PCT Guide, 537-

544

EP.05b PAGE FEE. As a general rule, the page fee is based on the international application

as published, regardless of the language of publication. The pages of the description, claims

and drawings are counted, plus one page in total for any pages with the bibliographic data and

the abstract. Amended claims under PCT Article 19 and/or PCT Article 34 are also considered

part of the international publication and must be taken into account unless the applicant has

indicated that the procedure in the European phase is not to be based on them. If (parts of) the

description and/or claims are amended on entry into the European phase, the amended pages of

the description and the amended set of claims replace the equivalent pages of the international

application as published and, consequently, form then the basis for calculating the page fee.

However, the calculation of the page fee cannot be based on pages of the description or of the

claims drafted partly in an official language of the EPO and partly in another language. Thus,

special rules for calculating the page fee apply if the international application was not published

in one of the official languages of the EPO and amendments are filed upon entry into the

European phase. Detailed information regarding the correct calculation of the page fee in such

case is provided in OJ EPO 2009, 338 and in the Guidelines for Examination in the EPO, A-III,

13.2. Completion of section 6 of EPO Form 1200 and the related table serves applicants to

clearly indicate to the EPO the documents on which the further proceedings are to be based and

to correctly compute the page fee.

Pages with amendments filed after expiry of the 31-month time limit are not taken into account

in calculating the page fee. Furthermore, page fees will not be refunded if the number of pages

is reduced during the proceedings before the EPO.

PCT Applicant’s Guide – National Phase – National Chapter – EP Page 9

(1 March 2018)

EPC Art. 79(2)

EPC Rules 39(1)

159(1)(d)

160

RFees Art. 2 No. 3

Euro-PCT Guide, 549

et seq.

EP.06 EUROPEAN DESIGNATION FEE. A (flat) designation fee must be paid within

six months from the publication by the International Bureau of the international search report or

before the expiration of the time limit applicable under PCT Articles 22(3) and 39(1)(b)

and EPC Rule 159 (31 months from the filing date or, if priority has been claimed, the earliest

priority date), whichever time limit expires later. If the designation fee is not paid in due time,

the Euro-PCT application will be deemed withdrawn.

Euro-PCT Guide, 556

et seq.

OJ EPO 2009, 603

OJ EPO 2015, A18-20

A84

A85

OJ EPO 2016, A5

A67

OJ EPO 2017, A85

OJ EPO 2018, A16

EP.07 EXTENSION/VALIDATION. International applications entering into the national

phase at the EPO (European phase) can be extended to or validated in certain States which

have concluded an Extension or Validation Agreement to that effect with the European Patent

Organisation (they are indicated in the Summary), provided the Extension/Validation

Agreement with the EPO was in force at the international filing date, the State concerned was

designated for a national patent in the international application and the respective

extension/validation fees have been paid, the amount of which is indicated in Annex EP.I. For

payment of the extension/validation fee, the provisions for payment of the European

designation fees apply mutatis mutandis. The request for extension/validation for a state is

deemed withdrawn if the extension/validation fee is not paid to the EPO within the time limit

laid down in the EPC for the payment of the designation fee (EPC Rule 159(1)(d)). If the

designation fee was paid but none of the extension/validation fees, no communication pointing

out the failure to observe the time limit for payment of the extension/validation fees is issued.

However, the applicant may still pay an extension/validation fee after expiry of the (basic) time

limit for payment of the designation fee and the extension/validation fees with a 50% surcharge

within a grace period of two months as from expiry of the basic time limit. Furthermore, where

in the absence of payment of the designation fee in due time further processing can be

requested in respect of the designation fee, the applicant may within two months from

notification of the communication of the loss of rights also pay the extension/validation fee(s)

with a 50% surcharge (see Guidelines for Examination in the EPO, A-III, 12.2). When an

extension State accedes to the EPC, the Extension Agreement remains applicable to

international applications filed prior to the date of accession.

EPC Rule 162

Euro-PCT Guide, 602

et seq.

EP.08 CLAIMS FEES. If the application documents on which the European grant

procedure is to be based contain more than fifteen claims, a claims fee is payable within the

31-month period in respect of the sixteenth and each subsequent claim. A higher claims fee is

payable in respect of the 51st and each subsequent claim. The claims fees must be calculated on

the basis of the number of claims specified to form the basis for the further proceedings on

entry into the national phase (that is, where amendments have been filed, the claims as

amended under PCT Article 19 or 34(2) or the claims as submitted by the applicant under

PCT Article 28 or 41 upon entering the national phase), unless the applicant uses the

opportunity to amend the claims in response to the communication pursuant to EPC Rules 161

and 162 referred to in paragraph EP.18, the claims thus amended being then used as the basis

for calculation of the claims fee and for the further proceedings. Where the applicant fails to

pay the correct amount of the claims fees within the 31-month time limit, the EPO will invite

him to pay the missing amount within the non-extendable six-month time limit set in the

communication under EPC Rules 161 and 162. Where the number of claims changes as a

consequence of a later (further) amendment filed in response to the communication pursuant to

Rules 161 and 162, that number is to be used as the basis for calculating the amount of the

claims fees to be paid. Where a claim fee is not paid in due time, a noting of loss of rights

(EPC Rule 112(1)) is issued, giving the applicant the opportunity to request further processing

(EPC Article 121) by paying the missing claims fee(s) together with the applicable fee for

further processing within a period of two months from notification of the communication. If

not paid within that period, the claim(s) concerned shall be deemed to be abandoned. Features

of a claim deemed to have been abandoned and which are not otherwise to be found in the

description or drawings cannot subsequently be reintroduced into the application and, in

particular, the claims.

EPC Rule 163(1), (6)

Euro-PCT Guide, 608-

610

EP.09 DESIGNATION OF THE INVENTOR. For details, see the form for such

designation in Annex EP.IV. Legalization is not required. For time limits, see the Summary.

Page 10 PCT Applicant’s Guide – National Phase – National Chapter – EP

(1 March 2018)

EPC Art. 133

134

EPC Rules 152

163(5), (6)

OJ EPO 2007, Special

Edition No. 3,

page 128 et seq.

Euro-PCT Guide, 459

et seq.

EP.10 APPOINTMENT OF AN AGENT AND POWER OF ATTORNEY. Natural and

legal persons having either their residence or their principal place of business within the

territory of one of the EPC contracting states may act on their own behalf in proceedings before

the EPO (EPC Article 133(1)). Natural and legal persons not having either a residence or their

principal place of business within the territory of one of the EPC contracting states must be

represented by a professional representative and act through him in all proceedings established

by the EPC (see the Summary, “Who can act as agent?”). In case of failure to appoint the

required professional representative, the applicant will be invited by the EPO to do so within

two months. If the deficiency is not corrected in due time, the application is refused.

Nevertheless, the applicant may act on his own behalf within the 31-month time limit

applicable under PCT Articles 22(3) and 39(1)(b) and EPC Rule 159(1). Under no

circumstances, however, may the applicant act through his agent appointed during the

international phase if the latter is not an agent entitled to practice before the EPO. Payments

can be made by anybody. A power of attorney (“Authorisation” or “General Authorisation”,

see samples given in Annexes EP.V and EP.VI, respectively), generally, need not be filed by an

agent who is a professional representative entered on the list maintained by the EPO. It is,

however, necessary that he informs the EPO of his appointment. This applies even if the

professional representative was appointed for the international phase, unless he was at the same

time also explicitly appointed for the European phase before the EPO acting as Receiving

Office. Legal practitioners entitled to practice before the EPO and employees representing an

applicant under EPC Article 133(3) who are not professional representatives must always file a

signed authorization or a reference to a general authorization already on file (for details, see the

Decision of the President of the EPO dated 12 July 2007 on the filing of authorizations,

OJ EPO 2007, Special edition No. 3, 128 et seq.). Only where the EPO acted as receiving

Office and the authorization expressly empowered the legal practitioner or employee to act

before the EPO in the national phase, is a new authorization not required. In the cases where a

power of attorney is required, the EPO will invite the applicant or agent to file it within a

period to be specified. If the authorization is not filed in due time, any procedural steps taken

by the agent will be deemed not to have been taken.

EPC Art. 86(1)

and (2)

EPC Rules 51

159(1)(g)

RFees Art. 2 No. 4, 5

Euro-PCT Guide, 599-

601

EP.11 RENEWAL FEES. They are payable for the third and each subsequent year

following the international filing date. Payment must be made before the expiration of the

month containing the anniversary of the international filing date. Payment can then still be

made, together with a 50% surcharge for late payment, before the expiration of the sixth month

after the month containing the anniversary of the international filing date. It is to be noted that

a renewal fee which is due within the 31-month time limit applicable under PCT Articles 22(3)

and 39(1)(b) can be paid without surcharge up to the expiration of the 31-month time limit.

The renewal fee can still validly be paid within six months after the expiration of the 31-month

time limit, subject to the payment of the 50% surcharge. If the renewal fee is not paid within

the six-month period, the application is deemed to be withdrawn. The failure to meet the time

limit for paying the renewal fee with surcharge may be remedied by filing a request for

re-establishment of rights (EPC Article 122, EPC Rule 136). The amounts of the renewal fees

are indicated in Annex EP.I. For the calculation of aggregate time limits, see OJ EPO 1993,

229, point II-3. Renewal fees may not be paid more than three months before they fall due.

EPC Art. 94

Euro-PCT Guide, 587-

589

EP.12 REQUEST FOR EXAMINATION. A European patent will be granted only if the

substantive examination of the application shows it to meet the requirements of the EPC.

Examination will only start upon explicit request. The request may be made by using the form

referred to in paragraph EP.01 (see pre-crossed box 4.1 of EPO Form 1200, Annex EP.III).

The request for examination is not deemed to be filed until after the examination fee has been

paid.

EPC Art. 94(2)

EPC Rule 159(1)(f)

Euro-PCT Guide, 590

EP.13 TIME LIMIT FOR REQUESTING EXAMINATION. Examination must be

requested within six months from the publication by the International Bureau of the

international search report or before the expiration of the time limit applicable under PCT

Articles 22(3) and 39(1)(b) and EPC Rule 159(1) (31 months from the filing date or, if priority

has been claimed, from the earliest priority date), whichever time limit expires later.

PCT Applicant’s Guide – National Phase – National Chapter – EP Page 11

(1 March 2018)

EPC Art. 94(1)

RFees Art. 14(2)

EP.14 FEE FOR EXAMINATION. The request for examination is only effective if the

examination fee has been paid. That fee must therefore be paid within the time limits set out in

paragraph EP.13. The amount of the said fee is indicated in Annex EP.I.

Euro-PCT Guide, 595

(i) It is reduced by 50% where an international preliminary report on patentability

(Chapter II) has been established by the EPO. If the report was established on certain parts of

the international application, the reduction is allowed only if examination is to be performed on

subject matter covered by the report.

EPC Art. 14(1)

EPC Rule 6(3)-(6)

RFees Art. 14(1)

Euro-PCT Guide, 594

OJ EPO 2014, A4, A23

(ii) Furthermore, a 30% reduction in the examination fee is available to SMEs, natural

persons, non-profit organizations, universities or public research organizations having their

residence or principal place of business in a EPC contracting state with an official language

other than English, French or German if they file the request for examination in an official

language of that state (“admissible non-EPO language”) and declare themselves to be entitled

to do so (EPC Rule 6(6)). Since the request for examination is only effective if the examination

fee has been paid, the request for examination in an admissible non-EPO language may still be

filed up until the examination fee is paid. If the request for examination in an admissible non-

EPO language is filed subsequently, it must be accompanied by a translation of the request for

examination in the procedural language. See also Annex EP.III, page 2, box 4.

RFees Art. 11

Euro-PCT Guide, 596

OJ EPO 2013, 153

(iii) If the conditions for both reductions are fulfilled, the examination fee is first

reduced by 50%. The 30% reduction is applied to the resulting total and not to the full fee.

Therefore, the total reduction in relation to the full fee is 65%.

RFees Art. 11(a), (b)

Euro-PCT Guide, 580-

581

OJ EPO 2016, A48, A49

The examination fee is refunded in full if the application is withdrawn, refused or deemed to be

withdrawn before substantive examination has begun. Fifty percent of the examination fee is

refunded if the application is withdrawn, refused or deemed to be withdrawn after the

examining division has begun but before expiry of the time limit for replying to the first

invitation under Article 94(3) EPC issued by the examining division, or if no such invitation

has been issued, before the date of the communication under Rule 71(3) EPC.

EPC Art. 121

EPC Rules 135

160

Euro-PCT Guide, 521

545-

548

553-

555

585-

586

597-

598

EP.15 CONSEQUENCES OF NON-FULFILMENT OF CERTAIN

REQUIREMENTS. EPC Rule 160 provides that if either the translation of the international

application or the request for examination is not filed in due time or if the filing fee, including

any additional fee for pages exceeding 35, the search fee, the examination fee or the

designation fee is not paid in due time, the European patent application is deemed withdrawn.

In these circumstances, the applicant will be informed of the deemed withdrawal and

EPC Rule 112(2) shall apply. However, the loss of rights shall be deemed not to have occurred

if, within two months of the EPO notification, further processing is requested by payment of the

respective fee(s) for further processing and the omitted act is completed.

If the applicant neither filed the request for examination nor paid the examination fee in due

time, further processing must be requested in respect of both omissions, i.e. in respect of filing

the request for examination and payment of the examination fee. It follows that the applicant

must file the request for examination and pay the examination fee itself together with two fees

for further processing: a flat fee for further processing in respect of the request for examination

and 50% of the examination fee.

EPC Art. 153(7)

EPC Rules 70

70a

161

Euro-PCT Guide, 569

et seq.

EP.16a SUPPLEMENTARY EUROPEAN SEARCH. As a rule, a supplementary

European search must be performed for each international application entering the European

phase and a search fee must be paid.

The supplementary European search will be based on the last set of (amended) claims available

to the EPO on the date of expiry of the time limit set under EPC Rule 161(2). Thus, any

amendment to the claims which has been filed up to that date will be taken into account (see

paragraph EP.18).

OJ EPO 2015, A94

Where the request for examination was filed before transmittal of the supplementary European

search report, which is usually the case, the EPO invites the applicant, after transmittal of the

supplementary European search report, to indicate whether he wishes to proceed further with

the application before the EPO. The applicant may waive the right to receive such

communication by informing the EPO thereof in due time.

Page 12 PCT Applicant’s Guide – National Phase – National Chapter – EP

(1 March 2018)

– If the applicant does not wish to proceed further, he may withdraw the application

or he may simply refrain from answering the invitation within the time limit fixed in it and the

application is deemed to be withdrawn. If the applicant wishes to proceed further, he must

notify the EPO accordingly. He may, at the same time, respond to the supplementary European

search report by filing amendments and/or comments on his application. The applicant is

required to reply to a search opinion within the time limit set by the EPO in its communication

under EPC Rule 70a(2) if the EPO has issued a negative written opinion (see Guidelines for

Examination in the EPO, B-XI, 8 and EP.18).

No supplementary European search performed:

Euro-PCT Guide, 574-

576

Dispensation applies and no search fee is to be paid if the international search report (or

supplementary international search report)1 was established by the EPO. In this case the

applicant will be invited to comment on the written opinion of the ISA or on the IPRP

(Chapter II), or on the supplementary international search report and to correct, if appropriate,

any deficiencies noted therein and to amend the application within six months2 from

notification of the invitation (EPC Rule 161(1)); see Guidelines for Examination in the EPO,

E-IX, 3.2 for more details.

Euro-PCT Guide, 582-

583

OJ EPO 2016, A2, A20

EP.16b SEARCH FEE. If a supplementary European search report is to be established, the

search fee must be paid within the 31-month time limit, and may be reduced as follows:

(i) by EUR 190 where the international search report was drawn up by the following

ISAs: the United States Patent and Trademark Office (USPTO), the Japan Patent Office (JPO),

the Korean Intellectual Property Office (KIPO), the State Intellectual Property Office of the

People’s Republic of China (SIPO), the Federal Service for Intellectual Property (Rospatent)

(Russian Federation) or the Australian Patent Office;

OJ EPO 2017, A57

(ii) by EUR 1,110 where the international search report was drawn up by the

Austrian Patent Office, the Finnish Patent and Registration Office, the Nordic Patent Institute,

the Spanish Patent and Trademark Office, the Swedish Patent and Registration Office, the

Turkish Patent and Trademark Office (Turkpatent) or the Visegrad Patent Institute. This

reduction also applies when a supplementary international search was established by the

Austrian Patent Office, the Finnish Patent and Registration Office, the Nordic Patent Institute,

the Swedish Patent and Registration Office, the Turkish Patent and Trademark Office

(Turkpatent) or the Visegrad Patent Institute.

OJ EPO 2014, A29

Euro-PCT Guide, 584

If the application claims the priority of an earlier application for which a search was carried out

by the EPO, (a part of) the fee paid for the supplementary European search may be refunded.

The level of any refund depends on the type of the earlier search and the extent to which the

EPO benefits from the earlier search report when carrying out the supplementary search.

EPC Rules 30

163(3)

Euro-PCT Guide, 527-

533

OJ EPO 11/2013, 542

EP.17 NUCLEOTIDE AND AMINO ACID SEQUENCES. If a Standard-compliant

sequence listing in TXT format is contained in the international application under

PCT Rule 5.2, furnished to the EPO acting as ISA/SISA or IPEA under PCT Rule 13ter.1(a) or

made accessible to the EPO by other means, the applicant does not have to submit the

Standard-compliant sequence listing again in TXT format on entry into the regional phase

before the EPO as designated or elected Office.

Where, however, a Standard-compliant sequence listing in TXT format is not available to the

EPO on the expiry of the period under Rule 159(1) EPC, the applicant will be invited to file a

Standard-compliant sequence listing in TXT format within a non-extendable period of two

months from the invitation and to pay the late furnishing fee. EPC Rule 30(2) and (3) and

Article 1 of the Decision of the President of the European Patent Office dated 28 April 2011 on

the filing of sequence listings (OJ EPO 6/2011, 372) are to be applied accordingly (see

EPC Rule 163(3) in conjunction with Article 5 of the above-mentioned decision of the

President).

Applicable as from 1 July 2010 (see OJ EPO 12/2009, 594).

Applicable as from 1 May 2011 (see OJ EPO 12/2010, 634).

PCT Applicant’s Guide – National Phase – National Chapter – EP Page 13

(1 March 2018)

If any deficiencies are not remedied in due time after such an invitation – this also applies to the

payment of the late furnishing fee – the application will be refused (EPC Rule 30(3)). The

applicant may request further processing of the application under EPC Article 121 EPC (see

also Notice from the European Patent Office dated 18 October 2013 concerning the filing of

sequence listings, OJ EPO 11/2013, 542 et seq.).

Furthermore, the applicant must enclose, together with the late filed sequence listing in TXT

format, a declaration to the effect that the sequence listing does not extend beyond the content

of the application as originally filed (see EPO Form 1200, Section 9.2). The filing of the

sequence listing on paper / in PDF format is not required. However, if the sequence listing is

also filed on paper / in PDF format, the applicant has to submit a statement that the sequence

listing in electronic form and on paper or in PDF format are identical.

EPC Rule 161(1), (2)

OJ EPO 2010, 634

Euro-PCT Guide, 483-

508

EP.18 AMENDMENT OF THE APPLICATION; TIME LIMITS. For the purpose of

the procedure before the EPO as designated/elected Office the applicant may always file

(voluntary) amendments within the 31-month time limit, and if he subsequently changes his

mind he may file (further) amendments until expiry of the time limit set in the combined

communication under EPC Rules 161 and 162. The applicant may also be required to file

(mandatory) amendments to and/or comments on the application within the time limit set in the

communication under EPC Rules 161 and 162. Whether or not a response is mandatory is

clearly stated in the communication, its wording thus differing depending on the case

(EPO Forms 1226AA, 1226BB or 1226CC).

The communication under EPC Rules 161 and 162 is issued for each application promptly once

the application has entered the European phase and on condition that the ISR is available to

the EPO. This means that it is also issued if the applicant has already filed, with Form 1200 or

thereafter, amendments and/or comments to form the basis for the procedure in the European

phase. Pursuant to EPC Rules 161 and 162 the time limit set in the communication is

six months. This time limit cannot be extended.

Euro-PCT Guide, 442

489-

491

OJ EPO 2015, A94

In order to accelerate the grant procedure the applicant can waive his right to the Rule 161/162

communication by crossing the box in Section 12.2, first checkbox, of EPO Form 1200. The

waiver will only be effective if any claims fees due for the set of claims indicated as the basis

for the procedure in the European phase have been paid and any mandatory substantive

response to the WO-ISA / the IPRP (Chapter II) / the SISR, established by the EPO, was filed

on entry into the European phase.

EPC Rule 70a(2)

70a(3)

137(3)

Euro-PCT Guide, 493

503

After expiry of the six-month time limit further possibilities for amending the application are

limited. If no supplementary European search is carried out, it is at the discretion of the

examining division to allow amendments. If a supplementary European search is carried out,

the applicant always has one further opportunity to submit amendments upon receipt of the

report. Thus, after issuance of the supplementary European search report the applicant may,

first of all, comment on both the report and the search opinion and file (voluntary) amendments

to the description, claims and drawings within the period specified in the communication under

EPC Rule 70a(2) for indicating whether he wishes to proceed further with the application.

Secondly, if any deficiencies are noted in the search opinion, the applicant will be required

under EPC Rule 70a(2) to respond to the objections made. The application will be deemed

withdrawn if the applicant does not submit a substantive reply to the communication under

EPC Rule 70a(2) (“mandatory response”). The loss of rights can be remedied by requesting

further processing. Amendments made thereafter require the consent of the examining division.

EPC Art. 123(2)

Amendments may under no circumstances go beyond the disclosure in the international

application as filed.

EPC Rule 137(4)

Whenever amendments are filed, the applicant must identify them and indicate their basis in the

application as filed. If he fails to do so, the examining division may issue a communication

requesting correction of the omission within a non-extendable time limit of one month. If the

deficiency is not remedied in due time, the application will be deemed withdrawn under

EPC Art. 94(4). The loss of rights can be remedied by requesting further processing.

EPC Art. 97(1)

EPC Rule 71(3)-(6)

EP.19 GRANTING OF THE EUROPEAN PATENT. Prior to the decision to grant the

European patent, the applicant will receive a communication containing both the text in which

the Examining Division intends to grant the European patent and an invitation to pay the grant

and printing fees and supply a translation of the claims in the two other official languages of

Page 14 PCT Applicant’s Guide – National Phase – National Chapter – EP

(1 March 2018)

the EPO. Performance of these acts implies approval of the text.3 If applicable, the

communication will also include an invitation to pay additional claims fees.

EPC Rule 71(3)

EP.20 FEE FOR GRANT, INCLUDING FEE FOR PUBLISHING AND CLAIMS

FEE. The amounts of the fees are indicated in Annex EP.I. They must be paid within four

months from the communication pursuant to EPC Rule 71(3) referred to in paragraph EP.19.

EPC Rule 71(3)

EP.21 TRANSLATION OF CLAIMS. Within the same period, the claims must be

translated into the two official languages of the EPO which are not the language of proceedings

(see paragraphs EP.02 and EP.19).

PCT Art. 23(2)

40(2)

EPC Rule 159(1)

Euro-PCT Guide, 427-

440

EP.22 EARLY PROCESSING OF NATIONAL PHASE. If the applicant wishes the

processing and the examination of his application to start earlier than the expiration of the time

limit applicable under PCT Article 22(3) or 39(1)(b), he must file an express request for early

processing. The request can be made by ticking the checkbox in section 12.1 of EPO

Form 1200. Moreover, the applicant must fulfill the requirements for entry into the European

phase as if the 31-month time limit provided for in EPC Rule 159(1) expired on the date he

requests early processing (see OJ EPO No. 3/2013, 156 et seq.).

PCT Art. 25

PCT Rule 51

82bis

EPC Rule 159(2)

Euro-PCT Guide, 637-

639

EP.23 REVIEW UNDER ARTICLE 25 OF THE PCT. The applicable procedure is

outlined in paragraphs 6.018 to 6.021 of the National Phase. At the request of the applicant,

the EPO may review whether a refusal by the receiving Office to accord a filing date, or a

declaration on the part of the receiving Office that a Euro-PCT application or the designation of

a state is considered withdrawn, or a finding by the International Bureau under PCT

Article 12(3) is the result of an error or omission on the part of the authority concerned, in

which case the Euro-PCT application can proceed as a European application.

To obtain such a review by the EPO as designated/elected Office, applicants must, within the

two-month time limit under PCT Rule 51.1, request the International Bureau under

PCT Art. 25(1) to send copies of documents in the files promptly to the EPO as designated

Office. Furthermore, the filing fee under EPC Rule 159(1)(c) must be paid and, where

required, a translation of the Euro-PCT application furnished within the same two-month time

limit (PCT Rule 51.3).

Applicants are recommended to undertake the remaining steps for entry into the European

phase under EPC Rule 159(1) at the same time.

EPC Art. 106

108

If, upon review under PCT Article 25, the EPO denies an error or omission on the part of the

receiving Office or the International Bureau, a notice of appeal against this decision may be

lodged within two months from the date of receipt of the decision. Within the same two-month

time limit, a fee for appeal must be paid (for the amount, see Annex EP.I). Within four months

from the date of receipt of the decision, grounds substantiating the notice of appeal must be

filed. The Board of Appeal will then decide on the appeal.

PCT Art. 24(2)

48(2)

PCT Rule 82bis

Euro-PCT Guide, 640

EP.24 EXCUSE OF DELAYS IN MEETING TIME LIMITS. Reference is made to

paragraphs 6.022 to 6.028 of the National Phase and to paragraph EP.15.

EPC Art. 121

EPC Rule 135

EP.25 FURTHER PROCESSING. Further processing of the application may be

requested where the applicant has missed a time limit during the international or the national

phase in respect of which further processing is not ruled out under Rule 135(2). If the request

is granted, this has the effect that the legal consequence of the failure to observe the time limit

is deemed not to have ensued. It must be made by completing the omitted act(s), as applicable,

and payment of the fee(s) for further processing, the amount of which is indicated in

Annex EP.I, within two months of the notification of the noting of loss of rights

(EPC Rule 112(1)). The fee for further processing varies depending on whether the loss of

rights occurred due to an omitted act (flat rate fee) or the late payment of a fee (50% of that

fee). In some cases, both fees for further processing have to be paid, e.g. if further processing

is requested for the late filing of the request for examination and the late payment of the

examination fee (see paragraph EP.15).

For information concerning amended Rule 71 and new Rule 71a EPC, see the Notice from the European Patent Office dated

13 December 2011, OJ EPO 2/2012, 52.

PCT Applicant’s Guide – National Phase – National Chapter – EP Page 15

(1 March 2018)

PCT Rule 82bis

EPC Art. 122

EPC Rule 136

EP.26 RE-ESTABLISHMENT OF RIGHTS. Re-establishment of rights may be

requested where the applicant lost any right because, in spite of all due care required by the

circumstances having been taken, he was unable to observe a time limit during the international

or the national phase. An application for re-establishment must be filed in writing within two

months from the removal of the cause of non-compliance with the time limit(s) but not later

than one year from the expiration of the time limit(s) which have not been observed. Within

the said two months, the omitted act(s) must be completed, the respective fee(s) for re-

establishment of rights (see Annex EP.I) must be paid and the request must state the grounds on

which it is based and must set out the facts on which it relies. However, reestablishment of

rights is ruled out in respect of any period for which further processing under EPC Article 121

is available. See Guidelines for Examination in the EPO, E-VIII, 3 for more details.

EPC Rule 53(2)

OJ EPO 8-9/2012, 492

Euro-PCT Guide, 613-

623

EP.27 PRIORITY DOCUMENTS. Where the priority of an earlier application is claimed

for a Euro-PCT application, the priority document is sent by the International Bureau to the

EPO, if the International Bureau received the priority document from the receiving Office or

directly from the applicant or was able to retrieve it from a digital library. Where for any

reason the priority document has not been submitted by the time of entry into the national

phase, the applicant will be invited to furnish the missing document(s) within two months from

the date of a notification under EPC Rule 163(2). This time limit cannot be extended. If the

priority document or the application number is not submitted within that time limit, the priority

right is lost. The loss of rights may be remedied by requesting further processing.

OJ EPO 2007 Special

Edition No. 3, A.3

OJ EPO 2014, A98

OJ EPO 2015, A27, A91

A priority document may be filed in electronic form with the EPO only if it is digitally signed

by the issuing authority and the signature is accepted by the EPO. A priority document cannot

be filed by fax.

No obligation to furnish the priority document:

The EPO as designated/elected Office will include a copy of the priority document free of

charge in the file of a Euro-PCT application even without having received a copy from the

International Bureau on condition that the applicant has informed the EPO of the application

number and only if the priority application is:

– a European patent application;

– an international application filed with the EPO as receiving Office;

– a Chinese patent or utility model application;

– a Japanese patent or utility model application;

– a Korean patent or utility model application;

– a United States provisional or non-provisional application.4

EPC Rule 53(3)

OJ EPO 2013, 150

Euro-PCT Guide, 624-

629

Where the language of priority documents is not one of the official languages of the EPO

(English, French or German) and the validity of the priority claim is relevant to the

determination of the patentability of the invention concerned, the applicant is invited to file,

within the time limit specified by the EPO, a translation in one of these three languages or a

declaration that the international application is a complete translation of the priority application.

Failure to comply with this invitation will result in the loss of the right of the relevant priority.

For further information see Guidelines for Examination in the EPO, A-III, 6.8.

PCT Rule 49ter.1

and .2

EPC Art. 122

OJ EPO 2007, 692

Euro-PCT Guide, 630-

636

EP.28 RESTORATION OF PRIORITY. If the international application was filed more

than 12 months from the filing date of the earlier application whose priority is claimed, the

applicant may file a request for restoration of priority with the EPO as designated/elected

Office.

A request for restoration of the right of priority under PCT Rule 49ter.2 may be granted

provided the following requirements are met:

– the filing date is within two months from the date on which the priority period

expired (PCT Rule 26bis.2(c)(iii));

See the Notice from the European Patent Office dated 27 June 2007 concerning practical aspects of the electronic exchange of

priority documents between the EPO and the USPTO in OJ EPO 8-9/2007, 473 et seq.

Page 16 PCT Applicant’s Guide – National Phase – National Chapter – EP

(1 March 2018)

– the failure to claim the right of priority within the priority period occurred in spite

of due care required by the circumstances having been taken; thus, the requirement of due care

is applied by the EPO in accordance with its standing practice under EPC Article 122;

– a request for restoration of priority is filed within one month from the date on

which the 31-month time limit for entry into the European phase expired

(PCT Rule 49ter.2(b)(i));

– the fee for restoration of priority levied by the EPO is duly paid within the same

time limit (PCT Rule 49ter.2(b)(iii));

– the request for restoration of priority is accompanied by a statement of reasons for

the failure and is preferably accompanied by any declaration or other evidence in support of the

statement of reasons (PCT Rule 49ter.2(b)(ii)).

EPC Art. 82

EPC Rule 164

OJ EPO 2014, A70

Euro-PCT Guide, 644-

649

EP.29 LACK OF UNITY. If upon expiry of the time limit set in the communication under

EPC Rules 161 and 162 for filing amendments, the documents that serve as the basis for the

supplementary European search or for examination contain claims relating to an invention that

was not searched by the EPO, and the application documents do not meet the requirement of

unity of invention, the procedure under EPC Rule 164 applies (see OJ EPO 2014, A70).

Euro-PCT Guide, 650-

655

The EPO did not act as (S)ISA:

– In this case the EPO draws up a partial supplementary European search report on

those parts of the application which relate to the invention first mentioned in the claims and

informs the applicant that, for the supplementary European search report to cover the other

inventions, a further search fee must be paid in respect of each invention involved, within

two months.

The EPO acted as (S)ISA:

– Where the supplementary European search report is dispensed with (see

EP.16a) and the examining division considers that in the application documents which are to

serve as the basis for examination an invention is claimed which was not searched by the EPO

as (S)ISA, the examining division shall inform the applicant that a search will be performed in

respect of any such invention for which a search fee is paid within a period of two months.

PCT Applicant’s Guide – National Phase – National Chapter – EP Annex EP.II, page 1

(1 March 2018)

Zeichen des Anmelders / Applicant’s

reference / Référence du demandeur

EPA/EPO/OEB 1200.1 – 03.18

Eintritt in die euro-

päische Phase (EPA

als Bestimmungsamt

oder ausgewähltes Amt)

Europäische Anmeldenummer oder, falls

nicht bekannt, PCT-Aktenzeichen oder

PCT-Veröffentlichungsnummer

Zeichen des Anmelders oder Vertreters

(max. 15 Positionen)

Anmelder

Die Angaben über den (die) Anmelder sind

in der internationalen Veröffentli chung

enthalten oder vom Inter natio nalen Büro

nach der internationalen Veröffentlichung

vermerkt worden.

Änderungen, die das Internationale Büro

noch nicht vermerkt hat, sind auf einem

Zusatzblatt angegeben.

Fehlende Angaben über den oder die

Anmelder sind auf einem Zusatzblatt

angegeben.

Zustellanschrift

(siehe Merkblatt II, 1)

Entry into the

European phase

(EPO as designated

RUHOHFWHG2I¿FH

European application number or, if

not known, PCT application or PCT

publication number

Applicant’s or representative’s reference

(max. 15 keystrokes)

Applicant

Indications concerning the applicant(s) are

contained in the international publication or

recorded by the International Bureau after

the international publication.

Changes which have not yet been

recorded by the International Bureau

are set out on an additional sheet.

Indications missing for the applicant(s)

are given on an additional sheet.

Address for correspondence

(see Notes II, 1)

Entrée dans la phase

européenne (l’OEB

agissant en qualité

G¶RI¿FHGpVLJQpRXpOX

Numéro de la demande de brevet

européen ou, à défaut, numéro de dépôt

PCT ou de publication PCT

Référence du demandeur ou du mandataire

(15 caractères ou espaces au maximum)

Demandeur

Les indications concernant le(s) deman -

GHXUV¿JXUHQWGDQVODSXEOLFDWLRQ

internationale ou ont été enregistrées par

le Bureau international après la publication

internationale.

Les changements qui n’ont pas encore été

enregistrés par le Bureau international sont

indiqués sur une feuille additionnelle.

Les indications manquantes concernant

un ou plusieurs demandeurs sont men-

tionnées sur une feuille additionnelle.

Adresse pour la correspondance

(voir notice II, 1)

An das Europäische Patentamt

7RWKH(XURSHDQ3DWHQW2I¿FH

$O¶2I¿FHHXURSpHQGHVEUHYHWV

Tag des Eingangs / Date of receipt / Date de réception

1XUIUDPWOLFKHQ*HEUDXFK)RURI¿FLDO

use only / Cadre réservé à l’administration

Annex EP.II, page 2 PCT Applicant’s Guide – National Phase – National Chapter – EP

(1 March 2018)

EPA/EPO/OEB 1200.2 – 03.18

Zeichen des Anmelders / Applicant’s

reference / Référence du demandeur

5HSUHVHQWDWLYH

Name and DGGUHVVRISODFHRIEXVLQHVV

(Name only one representative or

association of representatives, to be listed

in the Register of European Patents and to

ZKRPFRPPXQLFDWLRQVDUHWREHQRWL¿HG

Additional representative(s)

on additional sheet

Authorisation

Authorisation is attached.

General authorisation is registered

under No.:

$JHQHUDODXWKRULVDWLRQKDVEHHQ¿OHG

but not yet registered.

7KHDXWKRULVDWLRQ¿OHGZLWKWKH(32DV

3&7UHFHLYLQJ2I¿FHH[SUHVVO\LQFOXGHV

the European phase.

Request for examination

Examination of the application under

Article 94 EPC is hereby requested.

The examination fee is being (has been,

will be) paid.

Request for examination in an admissible

non-EPO language

The/Each applicant hereby declares that

he is an entity or a natural person under

Rule 6(4) EPC.

Copies

Additional copies of the documents cited in

the supplementary European search report

are requested.

Number of additional sets of copies

Mandataire

Nom et adresse professionnelle

(N’indiquer qu’un seul mandataire ou le

nom du groupement de mandataires qui

sera inscrit au Registre européen des bre-

YHWVHWDXTXHOOHVVLJQL¿FDWLRQVVHURQWIDLWHV

Fax / Téléfax

Autre(s) mandataire(s)

sur feuille supplémentaire

3RXYRLU

Un pouvoir est joint.

Un pouvoir général est enregistré

sous le n° :

Un pouvoir général a été déposé,

mais n’est pas encore enregistré.

Le pouvoir déposé à l’OEB agissant en

TXDOLWpG¶RI¿FHUpFHSWHXUDXWLWUHGX3&7

inclut expressé ment la phase européenne.

Requête en examen

Il est demandé par la présente que soit

examinée la demande de brevet conformé-

ment à l’article 94 CBE. Il est (a été, sera)

procédé au paiement de la taxe d’examen.

Requête en examen dans une langue

QRQRI¿FLHOOHDXWRULVpH

Le/Chaque demandeur déclare par la

présente être une entité ou une personne

physique au sens de la règle 6(4) CBE.

Copies

Prière de fournir des copies

supplémentaires des documents cités dans

le rapport complémentaire de recherche

européenne.

Nombre de jeux supplémentaires

de copies

Vertreter

Name und Geschäftsanschrift

(Nur einen Vertreter oder den Namen des

Zusammenschlusses angeben, der in das

Euro päische Patentregister einzutragen ist

und an den zugestellt wird)

Telefon / Telephone / Téléphone

Weitere(r) Vertreter

auf Zusatzblatt

Vollmacht

Vollmacht ist beigefügt.

Allgemeine Vollmacht ist registriert

unter Nr:

Allgemeine Vollmacht ist eingereicht,

aber noch nicht registriert.

Die beim EPA als PCT-Anmeldeamt

eingereichte Vollmacht schließt aus-

drücklich die europäische Phase ein.

Prüfungsantrag

Hiermit wird die Prüfung der Anmel dung

gemäß Artikel 94 EPÜ beantragt. Die

Prüfungsgebühr wird (wurde) entrich tet.

Prüfungsantrag in einer zugelassenen

Nichtamtssprache

Der/Jeder Anmelder erklärt hiermit, eine

Einheit oder eine natürliche Person nach

Regel 6 (4) EPÜ zu sein.

$EVFKULIWHQ

Zusätzliche Abschriften der im

ergänzenden europäischen Recherchen-

bericht angeführten Schriftstücke werden

beantragt.

Anzahl der zusätzlichen Sätze von

Abschriften

4.1

PCT Applicant’s Guide – National Phase – National Chapter – EP Annex EP.II, page 3

(1 March 2018)

EPA/EPO/OEB 1200.3 – 03.18

Zeichen des Anmelders / Applicant’s

reference / Référence du demandeur

Documents intended for

SURFHHGLQJVEHIRUHWKH(32

Proceedings before the EPO as

GHVLJQDWHG2I¿FH (PCT I) are to be

based on the following documents:

the DSSOLFDWLRQGRFXPHQWVSXEOLVKHG

by the International Bureau; where the

publication includes a set of claims

amended under Article 19 PCT, the latter

UHSODFHVWKHRULJLQDOO\¿OHGFODLPV

unless replaced by the amend ments

enclosed.

Comments on the written opinion esta-

blished by the EPO as the International

Searching Authority and/or observations

or, where applicable, on the explanations

given in the Supplementary Internatio-

nal Search Report established by the

EPO as the Supplementary International

Searching Authority (Rule 45bis.7(e) PCT)

Where necessary, further details should

be submitted on an additional sheet.

Proceedings before the EPO as elected

2I¿FH (PCT II) are to be based on the

following documents:

the documents on which the inter-

national preliminary examination

UHSRUWLVEDVHG, including any annexes

unless replaced by the amend ments

enclosed.

Comments on the international

preliminary examination report

established by the EPO as the

International Preliminary Examining

Authority and/or observations are

enclosed.

Where necessary, further details should

be submitted on an additional sheet.

If the EPO as International Prelimi nary

Examining Author ity has received test

reports, these may be used as the basis

of pro ceedings before the EPO.

Note on sections 6.1 and 6.2:

For applications comprising more than

35 pages, indications regarding the

calculation of the additional fee should be

given in the table on page 8.

For each of the previous applications

whose priority is claimed a copy is

attached of the search results produced

by the authority with which the application

ZDV¿OHG5XOH(3&

Pièces destinées à la procédure

GHYDQWO¶2(%

La procédure devant l’OEB agissant en

qualité d’RI¿FHGpVLJQp (PCT I) doit se

fonder sur les pièces suivantes :

les SLqFHVGHODGHPDQGHSXEOLpHV par

le Bureau international; lorsque la publica-

WLRQFRQWLHQWGHVUHYHQGLFDWLRQVPRGL¿pHV

conformément à l’article 19 PCT, ces der-

nières remplacent les revendications telles

que déposées initialement

dans la mesure où elles ne sont pas rem-

placées par les PRGL¿FDWLRQV join tes.

Commentaires sur l’opinion écrite établie

par l’OEB agissant en qualité d’administra-

tion chargée de la recherche internationale

et/ou observations, ou, le cas échéant,

FRPPHQWDLUHVVXUOHVH[SOLFDWLRQV¿JXUDQW

dans le rapport de recherche internatio-

nale supplémentaire établi par l’OEB

agissant en qualité d’administration

chargée de la recherche internationale

supplé mentaire (règle 45bis.7e) PCT)

Le cas échéant, des informations com-

plémentaires doivent être fournies sur

une feuille additionnelle.

La procédure devant l’OEB agissant en

qualité d’RI¿FHpOX (PCT II) doit se fonder

sur les pièces suivantes :

les pièces sur lesquelles se fonde le

rapport d’examen préliminaire inter-

national, y compris ses annexes éven-

tuelles

dans la mesure où elles ne sont pas rem-

placées par les PRGL¿FDWLRQV jointes.

Les commentaires sur le rapport

d’examen préliminaire international

établi par l’OEB agissant en qualité

d’administration chargée de l’examen

préliminaire international et/ou les

observations sont joints.

Le cas échéant, des informations com-

plémentaires doivent être fournies sur

une feuille additionnelle.

Si l’OEB, agissant en qualité d’administra -

tion chargée de l’examen prélimi naire inter-

national, a reçu des rapports d’essais,

ceux-ci peuvent être utilisés comme base

dans la procédure devant l’OEB.

Remarque concernant les rubriques

6.1 et 6.2 : pour les demandes comportant

plus de 35 pages, des indications relatives

au calcul de la taxe additionnelle doivent

¿JXUHUGDQVODWDEOHDXGHODSDJH

Il est joint une copie des résultats de toute

recherche effectuée par l’adminis tration au-

près de laquelle la (les) demande(s) anté-

rieure(s) dont la priorité est revendi quée a

(ont) été déposée(s) (règle 141(1) CBE).

)UGDV9HUIDKUHQYRUGHP(3$

EHVWLPPWH8QWHUODJHQ

Dem Verfahren vor dem EPA als

Bestimmungs amt (PCT I) sind fol gende

Unterlage n zugrunde zu legen:

die vom Internationalen Büro YHU|IIHQW

lichten Anmeldungsunter lagen; falls

die Veröffentlichung einen geänderten

Anspruchssatz gemäss Artikel 19 PCT

enthält, ersetzt dieser die ursprünglich

eingereichten Ansprüche

soweit sie nicht ersetzt werden durch

die beigefügten Änderungen.

Stellungnahmen zu dem vom EPA als

Internationaler Recherchen be hörde

erstellten schriftlichen Bescheid und/

oder Bemerkungen bzw. Stellungnah-

men zu den Erläuterungen in dem

vom EPA als mit der ergänzenden

internationalen Recherche beauftrag-

ten Behörde erstellten ergänzenden

internatio nalen Recherchenbericht

(Regel 45bis.7 e) PCT)

Soweit erforderlich, sind weitere Angaben

auf einem Zusatzblatt einzureichen.

Dem Verfahren vor dem EPA als aus-

ge wähltem Amt (PCT II) sind fol gende

Unter lagen zugrunde zu legen:

die dem LQWHUQDWLRQDOHQYRUOlX¿JHQ

3UIXQJVEHULFKW]XJUXQGHJHOHJWHQ

8QWHUODJHQ, ein schließlich etwaiger

An lagen

soweit sie nicht ersetzt werden durch

die beige fügten Än de rungen.

Stellungnahmen zu dem vom EPA

DOVPLWGHULQWHUQDWLRQDOHQYRUOlX¿JHQ

Prüfung beauftragter Behörde

HUVWHOOWHQLQWHUQDWLRQDOHQYRUOlX¿JHQ

Prüfungsbericht und/oder

Bemerkungen sind beigefügt.

Soweit erforderlich, sind weitere Angaben

auf einem Zusatzblatt einzureichen.

Sind dem EPA als mit der internatio-

QDOHQYRUOlX¿JHQ3UIXQJEHDXIWUDJWHU

Behörde 9HUVXFKVEHULFKWH zugegan gen,

dürfen diese dem Ver fahren vor dem EPA

zugrunde ge legt wer den.

Anmerkung zu den Feldern 6.1 und 6.2:

Bei Anmeldungen, die mehr als 35 Seiten

umfassen, sollen in der Tabelle auf Seite 8

Angaben betreffend die Berechnung der

Zusatzgebühren gemacht werden.

Eine Kopie der Recherchenergebnisse

der Behörde, bei der die frühere(n)

Anmeldung(en), deren Priorität bean-

sprucht wird, eingereicht wurde(n),

ist beigefügt (Regel 141 (1) EPÜ).

6.1

6.2

6.3

Annex EP.II, page 4 PCT Applicant’s Guide – National Phase – National Chapter – EP

(1 March 2018)

EPA/EPO/OEB 1200.4 – 03.18

Zeichen des Anmelders / Applicant’s

reference / Référence du demandeur

hEHUVHW]XQJHQ

Beigefügt sind die nachfolgend angekreuz-

ten Übersetzungen in einer der Amtsspra-

chen des EPA (Deutsch, Englisch, Franzö-

sisch):

a) Im Verfahren vor dem EPA als

Bestim mungsamt oder ausgewähltem

Amt (PCT I + II):

Übersetzung der internationalen Anmel-

dung in der ursprünglich eingereichten

Fassung (Beschreibung, An sprüche, etwai-

ge Text bestand teile in den Zeichnungen),

der veröffent lichten Zusammenfas sung und

etwai ger Angaben über bio lo gisches Mate-

rial nach Re ge l 13bis.3 und 13bis.4 PCT

Übersetzung der SULRULWlWVEHJUQGHQGHQ

Anmeldung(en) (nur nach Aufforderung

durch das EPA, Regel 53 (3) EPÜ)

Es wird hiermit erklärt, dass die interna-

tionale Anmeldung in ihrer ursprünglich

eingereichten Fassung eine vollständige

Übersetzung der früheren An meldung ist

(Regel 53 (3) EPÜ).

b) Zusätzlich im Verfahren vor

dem EPA als Bestimmungsamt (PCT I):

Übersetzung der nach Artikel 19 PCT

geänderten Ansprüche nebst Erklärung,

falls diese dem Verfahren vor dem EPA

zugrunde gelegt werden sollen (siehe

Feld 6).

c) Zusätzlich im Verfahren vor dem

EPA als ausgewähltem Amt (PCT II):

Übersetzung der Anlagen zum internatio-

QDOHQYRUOlX¿JHQ3UIXQJVEHULFKW

Biologisches Material

'LH(U¿QGXQJYHUZHQGHWXQGRGHUEH]LHKW

sich auf biologisches Material, das nach

Regel 31 EPÜ hinterlegt worden ist.

Die $QJDEHQQDFK5HJHOF(3h

(falls noch nicht bekannt, die Hinterle-

gungs stelle und das (die) vom Hinterleger

zugeteilte(n) Bezugszeichen [Nummer,

Symbole usw.]) sind in der internationalen

Veröffentli chung oder in der gemäß Feld 7

einge reichten Über setzung enthalten auf

Seite(n)/Zeile(n):

Die (PSIDQJVEHVFKHLQLJXQJHQ der

Hinterlegungsstelle

ist (sind) beigefügt.

wird (werden) nachgereicht.

9HU]LFKWDXIGLH9HUSÀLFKWXQJGHV$QWUDJ

stellers nach Regel 33 (2) EPÜ auf

gesondertem Schriftstück

Translations

7UDQVODWLRQVLQRQHRIWKHRI¿FLDO

langua ges of the EPO (English, French,

German) are enclosed as crossed below:

(a) In proceedings before the EPO as

GHVLJQDWHGRUHOHFWHG2I¿FH (PCT I + II):

Translation of the inter natio nal

ap plication (des cription, claims, any

text in the dra wings) DVRULJLQDOO\¿OHG,

of the ab stract as publis hed and of any

indica tion under Rule 13bis.3 and 13bis.4

PCT regarding biological material

Translation of the priority appli cation(s)

WREH¿OHGRQO\DWWKH(32¶VUHTXHVW

Rule 53(3) EPC)

It is hereby declared that the international

DSSOLFDWLRQDVRULJLQDOO\¿OHGLVDFRPSOHWH

translation of the previous application

(Rule 53(3) EPC).

(b) In addition, in proceedings before

the EPO as GHVLJQDWHG2I¿FH (PCT I):

Translation of amended claims and

any state ment un der Article 19 PCT, if

the claims as amended are to form the

basis for the procee dings before the EPO

(see Section 6).

the EPO as HOHFWHG2I¿FH (PCT II):

Translation of any annexes to the inter-

natio nal preliminary exami nation report

Biological material

The invention uses and/or relates to

biological material deposited under

Rule 31 EPC.

The particulars referred to in Rule 31(1)

LQVWLWXWLRQDQGWKHLGHQWL¿FDWLRQ

reference(s) [number, symbols, etc.] of the

depositor) are given in the international

publication or in the trans lation submitted

under Section 7 on page(s)/line(s):

The receipt(s) of deposit issued by the

depositary institution

is (are) enclosed.

ZLOOEH¿OHGODWHU

Waiver of the right to an undertaking from

the requester pursuant to Rule 33(2) EPC

attached

Traductions

Vous trouverez, ci-joint, les traductions

cochées ci-après dans l’une des langues

RI¿FLHOOHVGHO¶2(%DOOHPDQGDQJODLV

français) :

a) Dans la procé dure devant l’OEB

agissant en qualité d’RI¿FHGpVLJQp

RXpOX(PCT I + II) :

Traduction de la demande inter na -

tionale telle que déposée initiale ment

GHVFULSWLRQUHYHQGLFDWLRQVWH[WHV¿JXUDQW

éventuelle ment dans les des sins), de

l’abrégé publié et de toutes indications

visées aux règles 13bis.3 et 13bis.4 PCT

concernant le matériel biologique

Traduction de la (des) demande(s) dont

ODSULRULWpHVWUHYHQGLTXpH(à produire

seulement sur invitation de l’OEB,

règle 53(3) CBE)

Il est déclaré par la présente que la de-

mande internationale telle que déposée

initialement est une traduction intégrale de

la demande antérieure (règle 53(3) CBE).

b) De plus, dans la procédure devant l’OEB

agissant en qualité d’RI¿FHGpVLJQp (PCT I) :

Traduction des UHYHQGLFDWLRQVPRGL¿pHV

et de la déclaration faite confor mément

à l’article 19 PCT, si la pro cé dure devant

l’OEB doit être fondée sur les reven dications

PRGL¿pHVYRLUODUXEULTXH

c) De plus, dans la procédure devant l’OEB

agissant en qualité d’RI¿FHpOX (PCT II) :

Traduction des annexes du rapport

d’examen préliminaire inter national

0DWLqUHELRORJLTXH

L’invention utilise et/ou concerne de la

matière biologique déposée conformé ment

à la règle 31 CBE.

Les LQGLFDWLRQVYLVpHVjODUqJOHF

CBE (si elles ne sont pas encore connues,

l’autorité de dépôt et la (les) référence(s)

G¶LGHQWL¿FDWLRQ>QXPpURRXV\PEROHVHWF@

GXGpSRVDQW¿JXUHQWGDQVODSXEOLFDWLRQ

internationale ou dans la traduction pro-

du ite con formé ment à la rubrique 7 à la/aux

page(s)/ligne(s) :

Le(s) récépissé(s) de dépôt délivré(s)

par l’autorité de dépôt

est (sont) joint(s).

sera (seront) produit(s) ultérieurement.

Renonciation, sur document distinct,

à l’engagement du requérant au titre de

la règle 33(2) CBE

7.1

7.2

7.3

7.4

7.5

PCT Applicant’s Guide – National Phase – National Chapter – EP Annex EP.II, page 5

(1 March 2018)

EPA/EPO/OEB 1200.5 – 03.18

Zeichen des Anmelders / Applicant’s

reference / Référence du demandeur

Séquences de nucléotides et

d’acides aminés

Les pièces requises conformément aux

règles 5.2 et 13ter PCT et aux règles 30 et

163(3) CBE ont déjà été déposées auprès

de l’OEB.

Le listage des séquences sous forme

électronique est fourni ci-joint conformé-

ment aux règles 30 et 163(3) CBE.

Le listage des séquences ne s’étend pas

au-delà du contenu de la demande telle

qu’elle a été déposée.

Désignation d'Etats contractants

Tous les Etats contractants qui sont

parties à la CBE lors du dépôt de la

GHPDQGHGHEUHYHWLQWHUQDWLRQDOH et

sont désignés dans la demande inter-

nationale sont réputés désignés (voir

article 79(1) CBE).

Extension/Validation

La présente demande est réputée

constituer une requête en extension des

effets de la demande de brevet européen

et du brevet européen délivré sur la base

de cette demande à tous les Etats non

parties à la CBE qui sont désignés dans la

demande internationale et avec lesquels

des accords d’extension ou de validation

étaient en vigueur à la date du dépôt de

la demande. Cette requête est toutefois

réputée retirée si la taxe d’extension ou,

le cas échéant, la taxe de validation n’est

pas acquittée en temps utile.

Il est envisagé de payer la(les) taxe(s)

d’extension pour les Etats suivants :

Veuillez noter que dans le cadre de la

procédure de prélèvement automatique

des taxes d’extension, le compte est

débité du montant dû seulement pour les

Etats cochés ici, sauf instruction contraire

reçue avant l’expiration du délai de

paiement.

Bosnie-Herzégovine

Monténégro

(Espace prévu pour des Etats désignés dans

la demande internationale avec lesquels des

accords d’extension existaient à la date de

dépôt de la demande internationale)

Nucleotide and amino acid

sequences

The items pursuant to Rules 5.2 and

13ter PCT, Rules 30 and 163(3) EPC

are already with the EPO.

The sequence listing is furnished herewith

in electronic form in accordance with

Rules 30 and 163(3) EPC.

The sequence listing does not include

matter which goes beyond the application

DV¿OHG

Designation of contracting states

All the contracting states party to the EPC

DWWKHWLPHRI¿OLQJRIWKHLQWHUQDWLRQDO

patent application and designated in the

international application are deemed to be

designated (see Article 79(1) EPC).

Extension/Validation

This application is deemed to be a

request to extend the effects of the

European patent application and the

European patent granted in respect of it

to all non-contracting states to the EPC

designated in the international application

with which extension or validation

agreements were in force on the date on

ZKLFKWKHDSSOLFDWLRQZDV¿OHG+RZHYHU

the request is deemed withdrawn if the

extension fee or validation fee, whichever

is applicable, is not paid within the

prescribed time limit.

It is intended to pay the extension fee(s)

for the following state(s):

Note: Under the automatic debiting

procedure, extension fees will be debited

only for states indicated here, unless the

EPO is instructed otherwise before expiry

of the period for payment.

Bosnia and Herzegovina

Montenegro

(Space for states which were designated in

the international application and with which

extension agreements existed on the date

RI¿OLQJRIWKHLQWHUQDWLRQDODSSOLFDWLRQ

Nucleotid- und Aminosäure-

sequenzen

Die nach den Regeln 5.2 und 13ter PCT

sowie den Regeln 30 und 163 (3) EPÜ

erforderli chen Unterlagen liegen dem

EPA bereits vor.

Das Sequenzprotokoll wird anliegend in

elektronischer Form gemäß den Regeln

30 und 163 (3) EPÜ nachgereicht.

Das Sequenzprotokoll geht nicht

über den Inhalt der Anmeldung in

der ursprünglich eingereichten Form

hinaus.

%HQHQQXQJYRQ9HUWUDJVVWDDWHQ

Alle Vertragsstaaten, die dem EPÜ EHL

Einreichung der internationalen Patent-

anmeldung angehören, gelten als benannt

(siehe Artikel 79 (1) EPÜ), soweit sie in der

internationalen Anmeldung bestimmt sind.

Erstreckung/Validierung

Diese Anmeldung gilt als Antrag, die

europäische Patentanmeldung und das

darauf erteilte europäische Patent auf

alle in der internationalen Anmeldung

bestimmten Nichtvertragsstaaten des

EPÜ zu erstrecken, mit denen am Tag

der Einreichung der internationalen

Anmeldung Erstreckungs- oder Validie-

rungsabkommen in Kraft waren. Der

Antrag gilt jedoch als zurückgenommen,

wenn die Erstreckungs- bzw. die Validie-

rungsgebühr nicht fristgerecht entrichtet

wird.

Es ist beabsichtigt, die Erstreckungsge-

bühr(en) für folgende Staaten zu entrichten:

Hinweis: Im automatischen Abbuchungs-

verfahren werden nur für die hier ange-

kreuzten Staaten Erstreckungsgebühren

abgebucht, sofern dem EPA nicht vor

Ablauf der Zahlungsfrist ein anders-

lautender Auftrag zugeht.

BA Bosnien und Herzegowina

ME Montenegro

(Platz für in der internationalen Anmeldung

bestimmte Staaten, mit denen Erstreckungs-

abkommen am Anmeldetag der internatio-

nalen Anmeldung in Kraft waren)

9.1

9.2

10.

11.

11.1

Annex EP.II, page 6 PCT Applicant’s Guide – National Phase – National Chapter – EP

(1 March 2018)

EPA/EPO/OEB 1200.6 – 03.18

Zeichen des Anmelders / Applicant’s

reference / Référence du demandeur

11.2

12.

12.1

12.2

13.

14.

Es ist beabsichtigt, die Validierungsge-

bühr(en) für folgende Staaten zu entrichten:

Hinweis: Im automatischen Abbuchungs-

verfahren werden nur für die hier ange-

kreuzten Staaten Validierungsgebühren

abgebucht, sofern dem EPA nicht

vor Ablauf der Zahlungsfrist ein

anderslautender Auftrag zugeht.

KH Kambodscha

MA Marokko

MD Republik Moldau

TN Tunesien

(Platz für in der internationalen Anmeldung

bestimmte Staaten, mit denen Validierungs-

abkommen nach Drucklegung dieses

Formblatts in Kraft treten)

Beschleunigung des Verfahrens

9RU]HLWLJH%HDUEHLWXQJ

Hiermit wird die vorzeitige Bearbeitung

der Anmeldung gemäß Artikel 23 (2) /

40 (2) PCT beantragt („vorzeitiger

Bearbeitung in die europäische Phase“).

Î Bitte beachten Sie die Erfordernisse,

die für einen wirksamen Antrag auf vor -

zeitige Bearbeitung erfüllt werden müssen,

sowie dessen rechtliche Konsequenzen

(s. „Merkblatt zum Formblatt EPA 1200“).

Verzichtserklärungen

Der Anmelder verzichtet auf die Mitteilung

nach Regel 161 (1) oder (2) und 162 EPÜ.

Der Anmelder verzichtet auf die Aufforde-

rung nach Regel 70 (2) EPÜ, zu erklären,

ob die Anmeldung aufrechterhalten wird.

Zahlungen

Bezüglich der Gebührenentrichtung,

insbesondere über das laufende Konto,

wird auf Abschnitt 13 des Merkblatts

zum Formblatt für den Eintritt in

die europäische Phase (EPA als

Bestimmungsamt oder ausgewähltes

Amt) (Formblatt EPA/EPO/ OEB 1200)

verwiesen.

Etwaige Rückzahlungen sollen

DXIGDVXQWHQVWHKHQGHEHLP(3$

geführte laufende Konto erfolgen

Nummer und Kontoinhaber

It is intended to pay the validation fee(s)

for the following state(s):

Note: Under the automatic debiting

procedure, validation fees will be debited

only for states indicated here, unless the

EPO is instructed otherwise before expiry

of the period for payment.

Cambodia

Morocco

Republic of Moldova

Tunisia

(Space for states which were designated in

the international application and with which

validation agreements enter into force after

this form has been printed)

Acceleration of procedure

Early processing

Early processing of the application

pursuant to Article 23(2) / 40(2) PCT is

hereby requested (“early entry into the

European phase”).

Î Please take note of the further

requirements for the request to be

effective and the legal consequences

(see “Notes on EPO Form 1200”).

:DLYHUV

The applicant waives his right to the

communication under Rules 161(1) or (2)

and 162 EPC.

The applicant waives his right to be asked

under Rule 70(2) EPC whether he wishes

to proceed further with the application.

Payment

With regard to the payment of fees, in

particular via deposit account, reference is

made to Section 13 of the Notes on Form

EPA/EPO/OEB 1200 for entry into the

European phase (EPO as designated or

HOHFWHG2I¿FH

$Q\UHIXQGVVKRXOGEHPDGHWR

WKH(32GHSRVLWDFFRXQWEHORZ

Number and account holder

Il est envisagé de payer la(les) taxe(s) de

validation pour les Etats suivants :

Veuillez noter que dans le cadre de la

procédure de prélèvement automatique

des taxes de validation, le compte est dé-

bité du montant dû seulement pour les Etats

cochés ici, sauf instruction contraire reçue

avant l’expiration du délai de paiement.

Cambodge

Maroc

République de Moldavie

Tunisie

(Espace prévu pour des Etats désignés dans

la demande internationale avec lesquels des

accords de validation entreront en vigueur

après l’impression du présent formulaire)

Accélération de la procédure

Traitement anticipé

Par la présente, le traitement anticipé de

la demande selon les articles 23(2) / 40(2)

PCT est demandé (« entrée anticipée

dans la phase européenne»).

Î Prière de noter les conditions requises

à remplir pour qu’une requête en traite-

ment anticipé soit valable, ainsi que les

conséquences juridiques (voir la « Notice

concernant le formulaire OEB 1200 »).

Renonciations

Le demandeur renonce au droit de

UHFHYRLUODQRWL¿FDWLRQpPLVHHQYHUWXGHV

règles 161(1) ou (2) et 162 CBE.

Le demandeur renonce à être invité,

conformément à la règle 70(2) CBE, à dé-

clarer s’il souhaite maintenir sa demande.

Paiement

En ce qui concerne le paiement des taxes,

en particulier via un compte courant, ii

est fait reference a la rubrique 13 de la

notice concernant le formulaire EPA/EPO/

OEB 1200 relatif a l‘entree dans la phase

europeenne (OEB agissant en quallte

GµRI¿FHGHVLJQHRXHOX

/HVUHPERXUVHPHQWVpYHQWXHOV

GRLYHQWrWUHHIIHFWXpVVXUOH

compte courant ci-dessous

RXYHUWDXSUqVGHO¶2(%

Numéro et titulaire du compte

PCT Applicant’s Guide – National Phase – National Chapter – EP Annex EP.II, page 7

(1 March 2018)

EPA/EPO/OEB 1200.7 – 03.18

Zeichen des Anmelders / Applicant’s

reference / Référence du demandeur

15. 8QWHUVFKULIWHQGHVGHU

Anmelder(s) oder Vertreter

Name(n) des (der) Unterzeichneten bitte

in Druck schrift wiederholen und bei

juristischen Personen auch die Stellung

des (der) Unter zeichneten innerhalb der

Gesellschaft angeben.

Für Angestellte (Art. 133 (3) EPÜ)

mit allgemeiner Vollmacht Nr.:

Ort / Datum

Signature(s) of applicant(s) or

UHSUHVHQWDWLYH

Under signature please print name and,

in the case of legal persons, position

within the company.

For employees (Art. 133(3) EPC)

with general authorisation No.:

Place / Date

Signature(s) du (des) demandeur(s)

ou du mandataire

Prière d’indiquer en caractères d’im-

primerie le ou les noms des signataires

ainsi que, s’il s’agit d’une personne

morale, la position occupée au sein de

celle-ci par le ou les signataires.

Pour les employés (art. 133(3) CBE)

GLVSRVDQWG¶XQSRXYRLUJpQpUDOQ

Lieu / Date

Annex EP.II, page 8 PCT Applicant’s Guide – National Phase – National Chapter – EP

(1 March 2018)

EPA/EPO/OEB 1200.8 – 03.18

Zeichen des Anmelders / Applicant’s

reference / Référence du demandeur 8

Zeichen des Anmelders / Applicant’s

reference / Référence du demandeur

7DEHOOH]X)HOG

GHV)RUPEODWWV

7DEOHIRUVHFWLRQ

of Form 1200.3

7DEOHDXDIIpUHQW

jODUXEULTXH

du formulaire 1200.3

'HU%HUHFKQXQJGHU=XVDW]JHEKU]XJUXQGH]XOHJHQGH8QWHUODJHQ$UW1UD*HE2 1 /

'RFXPHQWVRQZKLFKWKHFDOFXODWLRQRIWKHDGGLWLRQDOIHHLVEDVHG

$UWLWHPD5)HHV1 / Pièces fondant le calcul de la taxe

DGGLWLRQQHOOHDUWSRLQWELV557 1

Seite(n) von ... bis ...2 Anzahl der Seiten3

Page(s) from ... to ...2 Number of pages3

Page(s) ... à ...2 Nombre de pages3

Anzahl der Seiten insgesamt / Total number of pages /

Nombre total de pages

Gebührenfreie Seiten (Art. 2 Nr. 1a GebO) / Fee-exempt pages (Art. 2, item 1a, RFees)

/ Pages exemptes de taxes (art. 2, point 1bis RRT)

$Q]DKOGHUJHEKUHQSÀLFKWLJHQ6HLWHQ1XPEHURISDJHVWREHSDLGIRU

Nombre de pages soumises au paiement de la taxe

Veröffentlichte Fassung der

inter nationalen Anmeldung /

International application as

published /

Demande internationale telle que

publiée

Geänderte Ansprüche nach Art. 19 PCT (veröffentlicht mit der internationalen

Anmeldung oder gesondert veröffentlicht) /

Amended claims under Art. 19 PCT (published with the international application or

published separately) /

5HYHQGLFDWLRQVPRGL¿pHVHQYHUWXGHO¶DUW3&7WHOOHVTXHSXEOLpHVDYHFOD

demande internationale ou telles que publiées séparément)

Beschreibung / description / description

Ansprüche / claims / revendications

Zeichnungen / drawings / dessins

Zusammenfassung / abstract / abrégé

Beschreibung / description / description

Ansprüche / claims / revendications

Zeichnungen / drawings / dessins

Beschreibung / description / description

Ansprüche / claims / revendications

Zeichnungen / drawings / dessins

Beim Eintritt in die europäische

Phase eingereichte Änderungen /

$PHQGPHQWV¿OHGRQHQWU\LQWR

European phase /

0RGL¿FDWLRQVSUpVHQWpHVORUVGH

l'entrée dans la phase européenne

Änderungen nach Art. 34 PCT /

Amendments under Art. 34 PCT /

0RGL¿FDWLRQVHQYHUWXGH

l'art. 34 PCT

– 35

(85

(x 15 EUR pro Seite) / (x EUR 15 per page) / (x 15 euros par page)

Zu entrichtender Gesamtbetrag

Total amount payable

Montant total exigible en euros

PCT Applicant’s Guide – National Phase – National Chapter – EP Annex EP.II, page 9

(1 March 2018)

EPA/EPO/OEB 1200.9 – 03.18

Fußnoten

Zu Fällen, in denen die internationale

Anmeldung nicht in einer Amtssprache

des EPA veröffentlicht wurde, siehe die

Mitteilung zur Ergänzung der Mitteilung

des Europäischen Patentamts vom

26. Januar 2009 über die Gebühren-

struktur 2009 (ABl. EPA 2009, 338).

In dieser Spalte sind nur die Seiten

an zu geben, die der Berechnung der

Zusatzgebühr (Art. 2, Nr. 1a GebO)

zugrunde zu legen sind. Verbleibende

Seiten/Teile der veröffentlichten Fassung

der Anmeldung und/oder der gemäß

Artikel 19 PCT und/oder Artikel 34

PCT geänderten Anmeldung, die zu

ersetzen sind, sind nicht in dieser Spalte

anzugeben.

In dieser Spalte ist nur die Zahl der

Seiten anzugeben, die der Berechnung

der Zusatzgebühr (Art. 2, Nr. 1a GebO)

zugrunde zu legen sind.

Footnotes

For cases where the international

application has not been published in

DQRI¿FLDOODQJXDJHRIWKH(32VHHWKH

Notice supplementing the Notice from the

(XURSHDQ3DWHQW2I¿FHGDWHG-DQXDU\

2009 concerning the 2009 fee structure

(OJ EPO 2009, 338).

Only those pages to be taken into

account for the calculation of the

additional fee (Art. 2, item 1a, RFees)

shall be indicated in this column.

Any remaining pages/parts of the

application as published and/or amended

under Article 19 PCT and/or Article 34

PCT which are to be replaced shall not

be indicated in this column.

Only the number of pages to be taken

into account for the calculation of the

additional fee (Art. 2, item 1a, RFees)

shall be indicated in this column.

1RWHVGHEDVGHSDJH

Pour les cas où à la demande inter-

nationale n’a pas été publiée dans une

ODQJXHRI¿FLHOOHGHO¶2(%FI&RPPXQLTXp

FRPSOpWDQWOHFRPPXQLTXpGHO¶2I¿FH

européen des brevets, en date du

26 janvier 2009, relatif à la structure

des taxes 2009 (JO OEB 2009, 338).

Il convient de n'indiquer dans cette

colonne que les pages devant être prises

en considération pour le calcul de la taxe

additionnelle (art. 2, point 1bis RRT).

Si la demande telle que publiée et/ou

PRGL¿pHDXWLWUHGHODUWLFOH3&7

et/ou de l'article 34 PCT contient

d'autres pages/parties qui doivent être

remplacées, prière de ne pas mentionner

les pages/parties en question dans cette

colonne.

Il convient de n'indiquer dans cette

colonne que le nombre de pages devant

être prises en considération pour le

calcul de la taxe additionnelle (art. 2,

point 1bis RRT).

Annex EP.II, page 10 PCT Applicant’s Guide – National Phase – National Chapter – EP

(1 March 2018)

EPO 1200 Notes 03.18

Notes on EPA/EPO/OEB Form 1200 for entry into the European phase

(EPO as designated or elected Office)

I. General instructions

These notes explain how to complete

EPA/EPO/OEB Form 1200. To file international

applications under the Patent Cooperation Treaty

(PCT) Form PCT/RO/101 should be used. The

appropriate form to request the grant of a

European patent is EPA/EPO/OEB Form 1001.

The requirements for entry into the European

phase are laid down in the European Patent

Convention (EPC) and its Implementing

Regulations. Further information on entry into the

European phase can be obtained from the Euro-

PCT Guide: PCT procedure at the EPO (10th

edition, January 2017), in particular Section E:

Euro-PCT procedure before the EPO as a

designated (PCT Chapter I) or elected (PCT

Chapter II) Office.

Forms and brochures

Forms, brochures, schedules of fees and legal

texts can be downloaded from the EPO's website

at www.epo.org.

Accelerated prosecution

For those seeking faster search or examination

for their applications, the "PACE" programme for

accelerated prosecution of European patent

applications (OJ EPO 2015, A93) offers effective

options for shortening the processing time.

However, PACE requests filed before the end of

the international phase will not be effective unless

accompanied by an express request for early

processing under Article 23(2) or 40(2) PCT (see

point 12.1).

For other ways to expedite the European grant

procedure, see Notice from the EPO dated

30 November 2015 (OJ EPO 2015, A94) and

point 12.

Entry into the European phase – Form 1200

Under Rule 159(1) EPC, on entry into the

European phase before the EPO as designated or

elected Office applicants must perform the acts

specified in Rules 159(1)(a) to (h) and 162(1)

EPC within 31 months of the filing date or, if

priority has been claimed, the (earliest) priority

date.

Use of Form 1200 is recommended. The form

should be typewritten or printed (Rule 50(2) EPC)

to ensure that it is machine-readable.

If there is not enough space for the required

information, an additional sheet should be filed,

indicating the number and heading (e.g. "2 -

Additional representative(s)"; "6 - Documents

intended for proceedings before the EPO") of

each section continued in this way.

Filing of documents

Form 1200 and attachments must be filed direct

with the EPO.

(a) Online

Form 1200, attached translations and

amendments to the application documents may

be filed in electronic form (OJ EPO 2015, A91),

i.e. via EPO online filing, via the EPO case

management system (CMS, also referred to as

new online filing) or via the EPO web-form filing

service. For more details go to www.epo.org. The

online filing fee is less than the fee for filing in

person, by post or by fax.

(b) By fax

The above documents may also be filed by fax.

Confirmation on paper is required only if the EPO

specifically requests it (see Special edition No. 3,

OJ EPO 2007, A.3.).

Form 1200 need only be filed in one copy. The

same applies to attached translations and

amendments to the application documents.

Special rules apply to sequence listings (see II.9).

II. Filling in the form

The numbering below corresponds to the sections

of the form.

1. Applicant

If on entry into the European phase the address,

nationality, or country of residence or of place of

business is missing for any applicant (as may

occur under Rule 26.2bis(b) PCT), this

information must be filed on a separate sheet.

PCT Applicant’s Guide – National Phase – National Chapter – EP Annex EP.II, page 11

(1 March 2018)

EPO 1200 Notes 03.18

An address for correspondence may be given

only by applicants who are not obliged to appoint

a professional representative authorised to act

before the EPO (Article 133 EPC) and have not

appointed one. It must be the applicant’s own

address, and in an EPC contracting state.

Addresses for correspondence accepted for

proceedings in the international phase but which

do not fulfil those conditions will not be accepted

in proceedings before the EPO in the European

phase (see OJ EPO 2014, A99).

2. Representative (Articles 133 and 134 EPC)

Applicants not having their residence or principal

place of business in an EPC contracting state

must be represented by a professional

representative and act through him in all

proceedings established by the EPC

(Article 133(2) EPC).

3. Authorisation (Rule 152 EPC)

Under Rule 152(1) to (3) EPC in conjunction with

the decision of the President of the EPO dated

12 July 2007, professional representatives who

identify themselves as such are required to file a

signed authorisation only in particular

circumstances (see Special edition No. 3,

OJ EPO 2007, L.1). However, a legal practitioner

entitled to act as professional representative

under Article 134(8) EPC or an employee acting

for an applicant under Article 133(3), first

sentence, EPC who is not a professional

representative must file a signed authorisation

unless an authorisation which expressly

empowers him to act in proceedings established

by the EPC has previously been filed with the

EPO as receiving Office.

If an association registered with the EPO is

appointed as representative (Rule 152(11) EPC)

(see OJ EPO 2013, 535), the association’s

registered name and registration number must be

indicated.

If an authorisation is required, the use of

EPA/EPO/OEB Form 1003 is recommended for

individual authorisations and EPO Form 1004 for

general authorisations.

4. Request for examination (Articles 150(2) and

94 and Rule 70 EPC)

4.1 First check box

The request for examination is not deemed to be

filed until the examination fee has been paid

(Article 94(1) and Rule 70(1) EPC). The box for

the request is pre-crossed in section 4.1 of

Form 1200.

Persons having their residence or principal place

of business in an EPC contracting state with an

official language other than English, French or

German, and nationals of that state who are

resident abroad, may file the request for

examination in an admissible non-EPO language

(Article 14(4) EPC), using the space provided.

4.1 Second check box

For applicants who file the request for

examination in an admissible non-EPO language

in addition to the (pre-crossed) request in the

language of the proceedings, the examination fee

is reduced by 30% provided they are an SME, a

natural person, a non-profit organisation, a

university or a public research organisation

(Rule 6(4) EPC, Article 14(1) RFees).

Under Rule 6(6) EPC, applicants wishing to

benefit from the fee reduction must declare that

they are an entity or natural person covered by

Rule 6(4) EPC. They must file this declaration at

the latest by the time of payment of the fee in

question, either by crossing this box or separately

(for this purpose, non-mandatory EPA/EPO/OEB

Form 1011 is available from the EPO website). If

there are multiple applicants, for the reduction to

apply each one must be an entity or a natural

person within the meaning of Rule 6(4) EPC and

entitled to file documents in an admissible non-

EPO language (Article 14(4), Rule 6(3) EPC). For

more details see Notice from the EPO dated

10 January 2014 concerning amended Rule 6

EPC and Article 14(1) RFees (OJ EPO, 2014,

A23).

The request for examination is available in all

admissible non-EPO languages on the EPO

website.

The request for examination (i.e. written request

plus payment of the examination fee) must be

filed either up to six months from the date on

which the international search report (or the

declaration under Article 17(2)(a) PCT) was

published (Article 153(6) EPC) or within

31 months from the filing date or, where

applicable, the (earliest) priority date, whichever

period ends later. In practice this means that the

request for examination must be submitted within

the 31-month period (Rule 159(1)(f) EPC), unless

the international search report was published late.

5. Additional copies of the documents cited in

the supplementary European search report

One or more additional sets of copies of the

documents cited in the supplementary European

search report (see Rule 65 EPC) can be ordered

against payment of the flat-rate fee(s).

6. Documents intended for proceedings before

the EPO (Rule 159(1)(b) EPC) and response to

the written opinion established by the EPO

(Rule 161(1) EPC)

When an application enters the European phase

applicants must specify the application

documents, as originally filed or as amended, on

Annex EP.II, page 12 PCT Applicant’s Guide – National Phase – National Chapter – EP

(1 March 2018)

EPO 1200 Notes 03.18

which the European grant procedure is to be

based (Rule 159(1)(b) EPC). Section 6 allows

them to clarify whether they wish to proceed with

• the published documents, whereby any

amended claims filed with the International

Bureau under Article 19 PCT replace the

originally filed claims, unless expressly stated

to the contrary – in proceedings before the

EPO as designated Office without PCT

Chapter II (section 6.1), or

• the documents on which the international

preliminary examination report is based –in

proceedings before the EPO as elected Office

under PCT Chapter II (section 6.2).

Sections 6.1 and 6.2 also provide the possibility to

indicate that amended documents filed on entry

into the European phase are to form the basis for

the grant procedure.

For Euro-PCT applications where a

supplementary European search report will not be

prepared, the following applies (see Guidelines for

Examination in the EPO, E-IX, 3.2, for details):

Where the EPO has acted as the International

Searching Authority (ISA) and, if a demand under

Article 31 PCT was filed, also as the International

Preliminary Examining Authority (IPEA), or as the

Supplementary International Searching Authority

(SISA), the applicant will be required to respond

to any negative written opinion (WO-ISA)

prepared by the EPO as ISA, or, where

applicable, to the negative international

preliminary examination report (IPER) prepared

by the EPO as IPEA, or to the objections raised in

the explanations given in the Supplementary

International Search Report (SISR) under

Rule 45bis.7(e) PCT, as the case may be. The

time limit for response is six months from the

invitation under Rule 161(1) EPC (see OJ EPO

2010, 634). Failure to respond in due time will

lead to the application being deemed to be

withdrawn (Rule 161(1) EPC).

New amendments (Articles 28 and 41 PCT)

and/or comments which are filed on entry into the

regional phase before the EPO will be considered

to constitute a response to the WO-ISA, or to the

IPER or the explanations given in the SISR, as

the case may be, if the applicant indicates on

Form 1200 that such amendments and/or

comments are to form the basis for further

prosecution of the application. Similarly,

amendments under Article 19 and/or 34 PCT filed

in the international phase and maintained on entry

into the European phase by making the

appropriate entries on Form 1200 may constitute

a response, subject to certain requirements (see

Guidelines for Examination in the EPO, C-III, 2.2,

and E-IX, 3, for details).

The applicant must therefore clearly indicate the

documents which are to form the basis for further

prosecution of the application by crossing the

appropriate boxes in section 6.1 or 6.2 as

applicable.

In all cases, the applicant should specify in the

table on page 8 of Form 1200 the documents

which are to be used for the European phase and

therefore form the basis for calculation of any

additional fee. Any exceptional circumstances

which may need further explanation must be

clarified on an additional sheet.

The applicant can also amend the application at

any time within a non-extendable period of six

months from the communication (Forms 1226AA,

1226BB, 1226CC) under Rule 161(1) and (2)

EPC, which is issued shortly after effective entry

into the European phase.

Pages of amendments filed during the six-month

period under Rule 161 EPC are not taken into

account in the calculation of the additional fee as

part of the filing fee. Consequently, if

amendments are filed at this stage which reduce

the number of pages already paid for, no refund of

the additional fee will be made.

If application documents filed on entry into the

European phase contain handwritten

amendments, an invitation to remedy this

deficiency will be issued, and in case of non-

compliance the application will be refused (see

Notice from the EPO dated 8 November 2013

concerning application of Rules 49 and 50 EPC to

handwritten amendments, OJ EPO 2013, 603).

Whenever amendments are filed, the applicant

must identify them and indicate the basis for them

in the application as filed (Rule 137(4) EPC) (see

Guidelines for Examination in the EPO, E-VIX,

3.4, and H-III, 2.1 and 2.1.1). If he fails to do so,

the examining division may issue a

communication under Rule 137(4) EPC

requesting the correction of the deficiency within a

non-extendable period of one month. If he then

fails to reply within that period, the application will

be deemed to be withdrawn under Article 94(4)

EPC.

If the applicant has supplied test reports in

proceedings before the EPO as International

Preliminary Examining Authority, the EPO

assumes that it may also use them in the

European grant proceedings.

6.3 Copies of the search results (Rule 141(1) EPC)

For each of the previous applications whose

priority is claimed, a copy of the search results

produced by the authority with which the

application was filed (Rule 141(1) EPC) has to be

supplied. This obligation applies to European

patent applications and international applications

PCT Applicant’s Guide – National Phase – National Chapter – EP Annex EP.II, page 13

(1 March 2018)

EPO 1200 Notes 03.18

filed on or after 1 January 2011 (see

OJ EPO 2010, 410, OJ EPO 2011, 64, and

OJ EPO 2013, 217).

This box is to be crossed only if the copies of the

documents are indeed supplied when filing the

form for entry into the European phase. If,

however, a copy of the search results is included

in the file by the EPO, no action is required on the

part of the applicant (see OJ EPO 2016, A19).

7. Translations

7.1 Translation of the international application

If the international application was not published

in an EPO official language, the applicant must

furnish the EPO with a translation of that

application in such a language within 31 months

of the filing date or, where applicable, the

(earliest) priority date.

The proceedings in the European phase will be

conducted in the language of the translation. The

translation must include the description, the

claims as originally filed, any text in the drawings,

and the abstract. It must also include any

indications under Rule 13bis.3 and 13bis.4 PCT in

the case of inventions relating to biological

material and any published request for

rectification (Rule 91.3(d) PCT).

7.2 Translation of the priority application

Under Rule 53(3) EPC, applicants may be invited

by the EPO to file a translation of the previous

(priority) application (see also OJ EPO 2013,

150).

Alternatively, they can submit a declaration under

Rule 53(3) that the European patent application is

a complete translation of the previous application.

They can do this by crossing the box in

section 7.3. In this case, no invitation to file a

translation of the priority application will be issued.

7.4 Claims amended under Article 19 PCT

If the applicant wishes the subsequent

proceedings to be based on the claims as

amended under Article 19 PCT, the translation

must also include those claims, together with any

explanatory statement (Rule 49.5(a)(ii), 49.5(c)

and (c-bis) PCT) and, in any event, the

accompanying letter under Rule 46.5(b) PCT.

7.5 Translation of annexes

Where PCT Chapter II applies, applicants must

prepare and file translations of all annexes to the

international preliminary examination report

(Article 36(2)(b) and (3)(b), Rule 70.16(a) PCT,

Rule 74.1 PCT), regardless of whether they are

seeking patent protection for the same version of

the application documents as was the subject of

that report.

8. Biological material

To enable the EPO to check compliance with

Rule 31 EPC, the receipt issued by the depositary

institution is to be submitted to the EPO.

Applicants are strongly advised to submit the

receipt when filing this form.

Waiver under Rule 33(1) and (2) EPC

Applicants may waive their right under Rule 33(1)

and (2) EPC to an undertaking from the requester

to issue a sample of the biological material,

provided that they are the depositor of the

biological material concerned. This waiver must

be expressly declared to the EPO in the form of a

separate, signed statement. It must specify the

biological material concerned (depositary

institution and accession number or depositor's

reference number as shown in the application

documents). It may be submitted at any time.

9. Nucleotide and amino acid sequences

9.1 If the application discloses one or more nucleotide

and/or amino acid sequences, a sequence listing

in electronic form complying with the

Administrative Instructions under the PCT (WIPO

Standard ST.25) is normally available to the EPO

as designated/elected Office if such sequence

listing was contained in the international

application in accordance with Rule 5.2(a) PCT,

furnished to the EPO as International Authority

under Rule 13ter.1(a) PCT, or otherwise made

available to it, e.g. by WIPO.

9.2 If the application discloses one or more nucleotide

and/or amino acid sequences and a sequence

listing in electronic form complying with the

Administrative Instructions under the PCT (WIPO

Standard ST.25) is not available to the EPO as

designated/elected Office, a standardised

electronic sequence listing must be filed on entry

into the European phase; otherwise, the EPO will

invite the applicant to file the sequence listing

(Rule 163(3) EPC). In this case, a late furnishing

fee is payable. For further information, see

Rules 163(3) and 30(3) EPC, as well as the

decision of the President of the EPO dated

28 April 2011 and the Notice from the EPO dated

18 October 2013 concerning the filing of

sequence listings (OJ EPO 2011, 372, and

OJ EPO 2013, 542).

If the standardised sequence listing is submitted

on entry into the European phase, the applicant

must declare that the subsequently filed sequence

listing does not include matter which goes beyond

the content of the application as originally filed.

The declaration can be made by crossing the

relevant box in section 9.2.

10. Designation of contracting states

All the contracting states designated in the

international patent application and party to the

EPC at the time of its filing are deemed to be

designated (see Article 79(1) EPC). Thus the EPC

Annex EP.II, page 14 PCT Applicant’s Guide – National Phase – National Chapter – EP

(1 March 2018)

EPO 1200 Notes 03.18

contracting states that can be validly designated

on entry into the European phase are already

specified in the international phase

(Rule 4.9(a) PCT). For international applications

entering the regional phase on or after

1 April 2009, payment of the flat-rate designation

fee covers all the EPC contracting states, unless

individual designations are expressly withdrawn

(Article 2, item 3, RFees) (see OJ EPO 2009,

118).

11. Extension/validation

The application and the European patent granted

in respect of it are extended or validated, in

accordance with section 11 of Form 1200, to

those non-EPC contracting states designated for

a national patent in the international application

with which extension or validation agreements

were in force at the time of filing of the

international application.

The request for extension or validation for a state

is deemed withdrawn if the extension/validation

fee is not paid to the EPO within the time limit laid

down in the EPC for paying the designation fee

(Rule 159(1)(d) EPC) (see Guidelines for

Examination in the EPO, A-III, 12).

11.1 Extension of European patent applications and

the resulting European patents may be requested

for countries with which the EPO has extension

agreements (as at March 2018: Bosnia and

Herzegovina and Montenegro).

11.2 Validation of European patent applications and

the resulting European patents may be requested

for countries with which the EPO has validation

agreements (as at March 2018: Morocco, the

Republic of Moldova, Tunisia and Cambodia). The

EPO publishes the necessary information about

such agreements on its website and in its Official

Journal in good time before their entry into force.

12. Acceleration of procedure

The ways in which the European grant procedure

can be expedited in addition to the "PACE"

request are listed in the Notice from the EPO

dated 30 November 2015 (OJ EPO 2015, A94).

The options available on entry into the European

phase are gathered together in this section for

ease of selection.

12.1 Early processing

Request for the early start of processing in the

European phase ("early entry")

Applicants who wish the EPO as designated or

elected Office to start processing an application

before expiry of the 31-month time limit under

Rule 159(1) EPC must file an express request for

early processing. The request can be made by

crossing box 12.1.

A request for early processing is effective on the

date of its filing only if the requirements of

Rule 159(1) EPC applicable on that date have

been complied with. The nature of the

requirements to be met depends on the date on

which the request for early processing is filed (see

Notice from the EPO dated 21 February 2013

concerning the request for early processing,

OJ EPO 2013, 156, II.7 and 8).

Applicants must take note of the consequences

of an effective request for early processing (see

OJ EPO 2013, 156, III.9 and 10). Crossing box

12.1 must therefore be carefully considered.

An effective request for early processing

terminates the international phase in respect of

the EPO as designated/elected Office. This

means that the application will be processed

immediately as a European application as from

the date the request for early processing is

effective, and reversion to the 31-month time limit

is excluded. This implies, for instance, that the

time limits for filing the request for examination

and paying the examination fee, the designation

fee and the third renewal fee are those applying to

a European application, and are no longer

deferred to expiry of the 31-month time limit under

Rule 159(1) EPC.

The automatic debiting of all relevant fees is

available for requests for early processing filed on

or after 1 November 2017 (see Arrangements for

the automatic debiting procedure (AAD,

Annexes A.1 and A.2 to the ADA)). However,

automatic debiting can only be performed if the

documents referred to in Article 20 PCT are

available to the EPO, so that it can establish

whether or not a page fee for the 36th and each

subsequent page must be debited. These

documents are normally available to the EPO if

– the international application has already been

published,

– the EPO is the receiving Office, or

– the EPO acts as (S)ISA or IPEA.

In all other cases, if they want the request to take

effect immediately, applicants must pay the

relevant fees due on filing the request for early

processing by a means of payment other than

automatic debiting. Otherwise the request will only

take effect on the day on which the EPO receives

the documents referred to in Article 20 PCT from

the IB in accordance with Rule 47.4 PCT.

PCT Applicant’s Guide – National Phase – National Chapter – EP Annex EP.II, page 15

(1 March 2018)

EPO 1200 Notes 03.18

Applicants are recommended to read the

Notice from the EPO dated 21 February 2013

concerning the request for early processing

(OJ EPO 2013, 156). Further information is

available in the Guidelines for Examination in

the EPO, E-IX, 2.8, and the Euro-PCT Guide,

10th edition, 427-440.

12.2 Waivers

Waiver of communication pursuant to Rules 161

and 162 EPC

The time limit under Rules 161 and 162 EPC is

six months (see OJ EPO 2010, 634).

In order to accelerate the European grant

procedure applicants can, in addition to filing a

"PACE" request, expressly waive their right to

the communication under Rules 161(1) or (2)

and 162 EPC by crossing the first box in

section 12.2.

The EPO will not issue a communication under

Rules 161(1) or (2) and 162 EPC only if, in

addition to the "waiver", on entry into the

European phase the applicant has also fulfilled all

the requirements of Rules 161 and 162 EPC (i.e.

payment of any claims fees due and, where

required, submission of a response under

Rule 161(1) EPC) for the application to proceed

directly to the supplementary European search or

to examination. To accelerate the processing of

the application further, the applicant can request

accelerated search or examination under the

PACE programme (see Notice from the EPO

dated 30 November 2015 concerning the

programme for accelerated prosecution of

European patent applications ("PACE"), OJ EPO

2015, A93).

Where the right to the communication under

Rules 161(1) or (2) and 162 EPC has not been

validly waived, the communication will be issued

and the application will be processed only after

expiry of the six-month period provided for under

those rules, even if a request under the PACE

programme has been filed.

See also Notices from the EPO dated 5 April 2011

and 30 November 2015 (OJ EPO 2011, 354 and

OJ EPO 2015, A94).

Waiver of the invitation under Rule 70(2) EPC

Applicants who file the request for examination

before receiving the supplementary European

search report are asked by the EPO, after the

search report has been sent, to confirm within a

six-month period that they wish to proceed further

with the application (Rule 70(2) EPC). Where they

also have to respond to the search opinion, their

response is required within this same period

(Rule 70a(2) EPC). To accelerate the procedure,

they can waive their right to be asked for such

confirmation by crossing the second box in

section 12.2, in which case confirmation is

deemed to be given when the supplementary

European search report is transmitted to them.

With regard to the legal consequences, see

Guidelines for Examination in the EPO, C-VI, 3.

13. Payment

Fees due in respect of a patent application can be

paid in a number of different ways, i.e. by debiting

a deposit account, by credit card or by bank

transfer. For more information, see "Making

payments" on the EPO website.

Debiting a deposit account/automatic debiting

The procedure for paying by debiting a deposit

account or by automatic debiting is set out in

detail in the Arrangements for deposit accounts

(ADA), the Arrangements for the automatic

debiting procedure (AAD, Annex A.1 to the ADA)

and the Information from the EPO concerning the

automatic debiting procedure (Annex A.2 to the

ADA) published in the supplementary publication

to the EPO’s Official Journal.

Careful attention should be paid to the conditions

applicable to the filing of debit orders.

Payment by credit card

Payments by credit card must be made via the

EPO’s credit card fee payment service available

on the EPO website, using a credit card accepted

by the EPO (as at December 2017: Master Card

and VISA). The procedure is set out in detail in

the Notice from the European Patent Office

concerning the payment of fees by credit card

published in the EPO’s Official Journal.

Bank transfers

The procedure for paying by bank transfer is set

out in detail in the Notice from the European

Patent Office concerning fee payments via bank

transfer published in the EPO’s Official Journal.

Payments by bank transfer should be made to the

following account with the Commerzbank in

Germany:

Account No. 3 338 800 00 / Sort code 700 800 00

IBAN DE20 7008 0000 0333 8800 00

BIC DRESDEFF700

Commerzbank AG

Leopoldstrasse 230

80807 Munich

Germany

For fee information, see "Guidance for the

payment of fees, costs and prices", which is

published regularly in the EPO's Official Journal.

Annex EP.II, page 16 PCT Applicant’s Guide – National Phase – National Chapter – EP

(1 March 2018)

EPO 1200 Notes 03.18

For the fee amounts, see the publication

"Schedule of fees and expenses" or the

"Interactive schedule of fees" available on the

EPO website "European (EPC) fees".

14. Refunds

Any refunds due to an applicant who has a

deposit account with the EPO may be credited to

that account. Applicants who wish this to be done

must indicate the account number and the

account holder’s name in this section. If the

account is held by a representative, refunds will

be made to him. Refunds will not be made to

third-party payers, except for the fee for file

inspection or at the express request of a party to

proceedings.

See also Guidelines for Examination in the EPO,

A-X, 10.4.

III. Table for section 6 of Form 1200.3 –

Documents intended for proceedings

before the EPO

The table is used for calculating the additional fee

for applications comprising more than 35 pages

(Article 2, item 1a, RFees). For further information

see the Euro-PCT Guide, part E-VII.

PCT Applicant’s Guide – National Phase – National Chapter – EP Annex EP.I, page 1

(1 March 2018)

FEES

(Currency: Euro)F

Filing fee:

– where the form for entry into the European phase (EPO Form 1200) is filed online ...... 120

– where the form for entry into the European phase (EPO Form 1200) is not filed online ... 210

Additional fee for pages in excess of 35:

for the 36th and each subsequent page ............................................. 15

Additional fee in the case of a divisional application filed in respect of any earlier application

which is itself a divisional application

– fee for a divisional application of second generation ............................. 210

– fee for a divisional application of third generation ............................... 425

– fee for a divisional application of fourth generation .............................. 635

– fee for a divisional application of fifth or any subsequent generation ................. 850

Designation fee for one or more EPO Contracting States designated ....................... 585

Extension fee for each extension State (extension of the European patent to certain States

which are not EPO Contracting States—see Summary) ................................ 102

Fee for validation of the European patent in:

– Cambodia:

........................................................... 180

– Morocco:

............................................................ 240

– Republic of Moldova:

................................................... 200

– Tunisia:

............................................................. 180

Claims fee:

– for the 16th and each subsequent claim up to the limit of 50 ........................ 235

– for the 51th and each subsequent claim ....................................... 585

Search fee in respect of a European or supplementary European search:

– for international applications filed before 1 July 2005 ............................ 885

– for international applications filed on or after 1 July 2005 ......................... 1,300

Fee for further processing:

– in the event of late payment of a fee ................................... 50% of the relevant fee

– in the event of late performance of the acts under Rule 71(3) EPC ................... 255

– other cases ............................................................ 255

Fee for late furnishing of a sequence listing ......................................... 230

Examination fee:

– for international applications filed before 1 July 2005 ........................ 1,825

– for international applications filed on or after 1 July 2005 for which no supplementary

European search report is drawn up ................................... 1,825

– for all other international applications filed on or after 1 July 2005 ................ 1,635

Renewal fees for European patent applications:1F2F2F

– for the 3rd year counted from the international filing date ......................... 470

– for the 4th year counted from the international filing date ......................... 585

– for the 5th year counted from the international filing date ......................... 820

– for the 6th year counted from the international filing date ......................... 1,050

– for the 7th year counted from the international filing date ......................... 1,165

This list is based on the Schedule of fees and expenses of the European Patent Office. For the currently valid version of this

Schedule reference is made to the Guidance for the payment of fees and expenses, in the latest issue of the OJ EPO on to the EPO’s

website.

Validation of the European patent in Cambodia is only available for international applications filed on or after 1 March 2018.

Validation of the European patent in Morocco is only available for international applications filed on or after 1 March 2015.

Validation of the European patent in the Republic of Moldova is only available for international applications filed on or after

1 November 2015.

Validation of the European patent in Tunisia is only available for international applications filed on or after 1 December 2017.

The obligation to pay renewal fees to the EPO ceases with the payment of the renewal fee due in respect of the year during which

the grant of the European patent has been published in the European Patent Bulletin.

Annex EP.I, page 2 PCT Applicant’s Guide – National Phase – National Chapter – EP

(1 March 2018)

– for the 8th year counted from the international filing date ......................... 1,280

– for the 9th year counted from the international filing date ......................... 1,395

– for the 10th and each subsequent year counted from the international filing date ......... 1,575

Additional fee for late payment of a renewal fee ............................... 50% of the relevant fee

Fee for grant3F3F

, including fee for printing the European patent specification:

– where the application documents to be printed comprise not more than 35 pages ........ 925

– where the application documents to be printed comprise more than 35 pages ........... 925

plus for the 36th and each subsequent page .................................... 15

Fee for grant4F4F

, including fee for publication of the European patent specification ............. 925

Fee for reestablishment of rights/fee for requesting restoration/fee for reinstatement of rights .... 640

Fee for appeal .............................................................. 1,880

Extract from the Rules Relating to Fees

Article 5

Payment of fees

(1) The fees due to the Office shall be paid in euro by payment or transfer to a bank account held by the Office.

(2) The President of the Office may allow other methods of paying fees than those set out in paragraph 1.

Article 6

Particulars concerning payments

(1) Every payment must indicate the name of the person making the payment and must contain the necessary

particulars to enable the Office to establish immediately the purpose of the payment.

(2) If the purpose of the payment cannot immediately be established, the Office shall require the person making the

payment to notify it in writing of this purpose within such period as it may specify. If he does not comply with

this request in due time the payment shall be considered not to have been made.

Article 7

Date to be considered as the date on which payment is made

(1) The date on which any payment shall be considered to have been made to the Office shall be the date on which

the amount of the payment or of the transfer is actually entered in a bank account held by the Office.

(2) Where the President of the Office allows, in accordance with the provisions of Article 5, paragraph 2, other

methods of paying fees than those set out in Article 5, paragraph 1, he shall also lay down the date on which

such payments shall be considered to have been made.

(3) Where, under the provisions of paragraphs 1 and 2, payment of a fee is not considered to have been made until

after the expiry of the period in which it should have been made, it shall be considered that this period has been

observed if evidence is provided to the Office that the person who made the payment

(a) fulfilled one of the following conditions in a Contracting State within the period within which the payment

should have been made:

(i) he effected the payment through a banking establishment;

(ii) he duly gave an order to a banking establishment to transfer the amount of the payment and

(b) paid a surcharge of 10% on the relevant fee or fees, but not exceeding EUR 150; no surcharge is payable if a

condition according to sub-paragraph (a) has been fulfilled not later than ten days before the expiry of the

period for payment.

(4) The Office may request the person who made the payment to produce evidence as to the date on which a

condition according to paragraph 3(a) was fulfilled and, where required, pay the surcharge referred to in

paragraph 3(b), within a period to be specified by it. If he fails to comply with this request or if the evidence is

insufficient, or if the required surcharge is not paid in due time, the period for payment shall be considered not

to have been observed.

Applicable to international applications entering the regional phase before 1 April 2009.

Applicable to international applications entering the regional phase on or after 1 April 2009.

PCT Applicant’s Guide – National Phase – National Chapter – EP Annex EP.I, page 3

(1 March 2018)

Article 8

Insufficiency of the amount paid

A time limit for payment shall in principle be deemed to have been observed only if the full amount of the fee has

been paid in due time. If the fee is not paid in full, the amount which has been paid shall be refunded after the period

for payment has expired. The Office may, however, in so far as this is possible within the time remaining before the

end of the period, give the person making the payment the opportunity to pay the amount lacking. It may also,

where this is considered justified, overlook any small amounts lacking without prejudice to the rights of the person

making the payment.

Article 9

Refund of search fees

(1) The search fee paid for a European or supplementary European search shall be fully refunded if the European

patent application is withdrawn or refused or deemed to be withdrawn at a time when the Office has not yet

begun to draw up the search report.

(2) Where the European search report is based on an earlier search report prepared by the Office on an application

whose priority is claimed or an earlier application within the meaning of Article 76 of the Convention or of

Rule 17 of the Convention, the Office shall refund to the applicant, in accordance with a decision of its

President, an amount which shall depend on the type of earlier search and the extent to which the Office

benefits from the earlier search report when carrying out the subsequent search.

Article 11

Refund of examination fee

The examination fee shall be refunded:

(a) in full if the European patent application is withdrawn, refused or deemed to be withdrawn before substantive

examination has begun;

(b) at a rate of 50% if the European patent application is withdrawn after substantive examination has begun and

before expiry of the time limit for replying to the first invitation under Article 94, paragraph 3, of the

Convention issued by the Examining Division proper or, if no such invitation has been issued by the Examining

Division, before the date of the communication under Rule 71, paragraph 3, of the Convention.

Article 14

Reduction of fees

(1) The reduction laid down in Rule 6, paragraph 3, of the Convention shall be 30% of the filing fee or examination

fee.

(2) Where the European Patent Office has drawn up an international preliminary examination report, the

examination fee shall be reduced by 50%. If the report was established on certain parts of the international

application in accordance with Article 34, paragraph 3(c), PCT, the fee shall not be reduced if subject-matter

not covered by the report is to be examined.

Extract from the Arrangements for deposit accounts which may be used for the settlement of

fees or the cost of publications and other services payable to the EPO2F5F5F

1. General provisions

Under Articles 5(2) and 7(2) of its Rules relating to Fees (RFees), the EPO makes available, for any interested

natural or legal person (or bodies equivalent to a legal person under the law applicable to them), deposit accounts for

paying fees, expenses and prices to the EPO. Deposit accounts are kept in euro only, at EPO headquarters in

Munich.

2. Formalities for opening and closing an account

2.1 A deposit account may be opened at the request of the prospective account holder. He must provide all the

necessary particulars about his person, occupation and address. This is done by completing and submitting the

online request form on the EPO website under “Applying for a patent -> Forms and fees -> Making payments”.

If his contact details change, the account holder must inform the EPO accordingly, also using the online request

form.

Arrangements for deposit accounts (ADA) and their annexes (valid as from 1 December 2017): See Supplementary publication 5,

OJ EPO 2017.

Annex EP.I, page 4 PCT Applicant’s Guide – National Phase – National Chapter – EP

(1 March 2018)

2.2 A deposit account may be closed at the signed written request of the deposit account holder or his successors

in title, filed by email attachment sent to support@epo.org, or by completing and submitting the online form

available on the EPO website under “Applying for a patent -> Forms and fees -> Making payments” together with

the signed written request. From the request it must be evident that the requester and the deposit account holder are

the same person.

Successors in title must provide the EPO with documentary proof of their entitlement.

2.5 A deposit account can be re-opened at the request of the original account holder, made by crossing the

appropriate box in the online request form referred to in point 2.1.

3. Replenishments, repayments and transfers between deposit accounts

3.1 Once the deposit account has been opened, its number is communicated to the holder, who must then make an

initial payment commensurate with his requirements and the intended frequency of replenishment, so as to ensure

that there are sufficient funds in the account.

3.2 Payments to replenish deposit accounts must be made into the EPO’s bank account.

The payment must

include the following information in the reference field of the bank transfer: “replenishment” (or “repl” for short) or

“deposit”, followed by the eight-digit number (starting with 28) of the EPO deposit account concerned. They are

credited to the deposit account as of the date on which the payment is actually entered in the EPO bank account.

5. Debiting the account

Subject to point 8, deposit accounts may be debited only in respect of fees, expenses and prices payable to the EPO

in connection with European and PCT proceedings.

5.1. Types of debit orders and accepted means of filing

5.1.1 Debiting occurs only on the basis of an electronic debit order signed by the account holder or the authorised

representative. The signature may take the form of a text string signature, a facsimile signature, an enhanced

electronic signature,

or authentication with smart card if payment is made via Online Fee Payment in Online

services.

The debit order may be:

– a debit order for individual fees for one or more applications, i.e. a single or a batch debit order, or

– an automatic debit order

for a specific European or international patent application, authorising the EPO to

debit fees automatically as the proceedings progress.

5.1.2 The debit order must be filed in an electronically processable format (XML) via one of the following:

– EPO Online Filing or the EPO Case Management System (CMS), using EPO Forms 1001E, 1200E, 2300E

or 1038E;

– the EPO Online Filing software or PCT-SAFE, CMS and ePCT using the PCT fee calculation and payment

feature;

– Online Fee Payment in Online services.

5.1.3 Debit orders submitted in any other way, e.g. on paper, by fax, via the web-form filing service or using a

different format such as a PDF attachment, are invalid and thus will not be carried out. The EPO will inform the

party to the proceedings accordingly, as a courtesy service. The legal consequence of filing an invalid debit order is

laid down in point 5.4.2.

5.4 Payment date

5.4.2 If a debit order is submitted via a non-accepted means of filing or in an invalid format, the date of receipt will

not be regarded as the payment date. If this means that a time limit for paying a fee has expired, the party to the

proceedings

may make use of any of the legal remedies available under the EPC or the PCT.

The following account with the Commerzbank in Germany is available for payments and transfers from all member states:

Nr. 3 338 800 00 (BLZ 700 800 00), IBAN DE20 7008 0000 0333 8800 00, BIC DRESDEFF700, Commerzbank AG,

Leopoldstrasse 230, 80807 München, Germany.

For further details, see the decision of the President dated 15 November 2015 concerning the electronic filing of documents

(OJ EPO 2015, A91).

See point 7 ADA, the Arrangements for automatic debiting (Annex A.1 in this supplementary publication) and information from

the EPO concerning the automatic debiting procedure (Annex A.2, loc. cit.).

The payment of all fees related to PCT proceedings at the EPO may be indicated via the online filing PCT-SFD plug-in.

A party to the proceedings may be e.g. an applicant, opponent, appellant or, if the party is represented, its international agent or

European representative.

PCT Applicant’s Guide – National Phase – National Chapter – EP Annex EP.I, page 5

(1 March 2018)

5.5 Unavailability of the accepted electronic means of filing debit orders

If a payment period expires on a day on which one of the accepted means of filing debit orders under point 5.1.2 is

not available at the EPO, the payment period is extended to the first day thereafter on which all such means as are

available for the type of application concerned can be accessed again. In the event of a general unavailability of

electronic communication services, or if other like reasons within the meaning of Rule 134(5) EPC or

Rule 82quater.1 PCT arise, payment periods are extended in accordance with these provisions.

7. Automatic debiting procedure

Deposit account holders may have their accounts debited automatically on the basis of an automatic debit order. The

conditions applicable, and in particular the types of proceedings and fees covered, are laid down in the Arrangements

for the automatic debiting procedure (AAD).

Extract from the decision of the President of the European Patent Office concerning the

payment of fees by credit card

The President of the European Patent Office, having regard to Articles 5(2) and 7(2) of the Rules relating to Fees,

has decided as follows:

Article 1

Credit card as a method of fee payment

Fees due to the EPO may be paid by credit card under the conditions set forth in the present decision.

Article 2

Conditions for use

Payments by credit card must be made in euro via the EPO’s credit card fee payment service, using a credit card

accepted by the EPO.

Article 3

Date of payment

Payment by credit card is deemed to have been made on the date on which the transaction is approved. This date is

indicated in the transaction confirmation made available to the payer.

Article 5

Entry into force

This decision enters into force on 1 December 2017.

See Annex A.1 in this supplementary publication. See also Annex A.2 in this supplementary publication for information from the

EPO concerning the automatic debiting procedure.

Decision of the President and Notice from the European Patent Office dated 22 August 2017 concerning the payment of fees by

credit card: See OJ EPO 2017, A72 and A73.

PCT Applicant’s Guide – National Phase – National Chapter – EP Annex EP.III, page 1

(1 April 2008)

In Sachen der oben bezeichneten europäischen Patentanmeldung nennt (nennen) der (die) Unterzeichnete(n)1 / In respect of the above European patent application

I (we), the undersigned1 / En ce qui concerne la demande de brevet européen susmentionnée, le(s) soussigné(s)1

als Er nder 2 : / do hereby designate as inventor(s)2: / désigne(nt) en tant qu’inventeur(s)2 :

Weitere Er nder sind auf einem gesonderten Blatt angegeben. / Additional inventors are indicated on a supplementary sheet. /

D'autres inventeurs sont mentionnés sur une feuille supplémentaire.

Der (Die) Anmelder hat (haben) das Recht auf das europäische Patent erlangt 3 / The applicant(s) has (have) acquired the right to the European patent3 /

Le(s) demandeur(s) a (ont) acquis le droit au brevet européen3

gemäß Vertrag vom / als Arbeitgeber / durch Erbfolge /

by an agreement dated / as employer(s) / as successor(s) in title /

en vertu du contrat passé le en qualité d’employeur(s) par succession

bitte wenden / P.T.O. / T.S.V.P.

Zeichen des Anmelders / Applicant’s reference /

Référence du demandeur

(max. 15 Positionen / max. 15 spaces / 15 caractères au maximum)

Name des (der) Unterzeichneten bitte in Druckschrift wiederholen. Bei juristischen Personen bitte die Stellung des (der) Unterzeichneten innerhalb der

Gesellschaft in Druckschrift angeben. / Please print name(s) under signature(s). In the case of legal persons, the position of the signatory within the company

should also be printed. / Le ou les noms des signataires doivent être indiqués en caractères d‘imprimerie. S’il s’agit d’une personne morale, la position occupée

au sein de celle-ci par le ou les signataires doit également être indiquée en caractères d‘imprimerie.

Ort / Place / Lieu

(falls Anmelder nicht oder nicht allein der Er nder ist) /

(where the applicant is not the inventor or is not the sole inventor) /

(si le demandeur n’est pas l’inventeur ou l’unique inventeur)

Unterschrift(en) des (der) Anmelder(s) oder Vertreter(s): /

Signature(s) of applicant(s) or representative(s): /

Signature(s) du (des) demandeur(s) ou du (des) mandataire(s) :

Datum / Date

EPA/EPO/OEB 1002 12.07

Anmeldenummer oder, falls noch nicht bekannt, Bezeichnung der Er ndung: /

Application No. or, if not yet known, title of the invention: /

No de la demande ou, s‘il n’est pas encore connu, titre de l’invention :

Er ndernennung

Designation of inventor

Désignation de l’inventeur

Annex EP.III, page 2 PCT Applicant’s Guide – National Phase – National Chapter – EP

(1 April 2008)

EPA/EPO/OEB 1002 12.07

Fußnoten zur Vorderseite

1 Name(n) des (der) Unterzeichneten nach

Maßgabe der Regel 41 (2) c) und d) EPÜ:

Bei natürlichen Personen ist der Familienname

vor den Vornamen anzugeben.

Bei juristischen Personen und Gesellschaften,

die juristischen Personen gemäß dem für sie

maß gebenden Recht gleich ge stellt sind, ist die

amtliche Bezeichnung anzugeben.

2 Name(n), Vorname(n) und vollständige

Anschrift(en) des Er nders (der Er nder)

gemäß Regel 19 (1) EPÜ.

3 Ist der Anmelder nicht oder nicht allein der

Er nder, so hat die Er ndernennung eine

Erklärung darüber zu enthalten, wie der An-

melder das Recht auf das euro päische Patent

erlangt hat (Artikel 81, Regel 19 (1) EPÜ).

Bei rechtsge schäft licher Übertragung genügt

die Angabe „gemäß Vertrag vom ...“.

Bei Arbeit nehmerer ndungen genügt der

Hinweis, dass der oder die Er nder Arbeit-

nehmer des Anmelders/der An melder ist bzw.

sind.

Bei Erbfolge genügt die Angabe, dass

der oder die Anmelder Erbe(n) des Er nders/

der Er nder ist bzw. sind.

Renvois concernant le texte  gurant

au recto

1 Nom(s) du (des) soussigné(s), conformément

à la règle 41(2)c) et d) CBE :

Les personnnes physiques doivent être désig-

nées par leurs noms suivis de leurs prénoms.

Les personnes morales et les sociétés assimi-

lées aux personnes morales en vertu du droit

dont elles relèvent doivent  gurer sous leur

désignation of cielle.

2 Nom(s), prénom(s) et adresse(s) complète(s)

de l’(des) inventeur(s), conformément à la

règle 19(1) CBE.

3 Si le demandeur n’est pas l’inventeur, ou

l’unique inventeur, la désignation de l’inventeur

doit comporter une déclara tion indiquant

l’origine de l’acquisition du droit au brevet

européen (article 81 et règle 19(1) CBE).

En cas de transfert contractuel, il suf t de

mentionner « en vertu du contrat

passé le ... ».

Pour les inventions de salariés, il suf t

d‘indiquer que le ou les inventeurs sont des

employés du ou des demandeurs.

En cas de transfert successoral, il suf t

d’indiquer que le ou les demandeurs sont les

héritiers du ou des inventeurs.

Footnotes to text overleaf

1 Name(s) of the undersigned in accordance

with Rule 41(2)(c) and (d) EPC:

Names of natural persons shall be indicated

by the person’s family name, followed by his

given names.

Names of legal persons, and of bodies equi-

valent to legal persons under the relevant law,

shall be indicated by their of cial designations.

2 Family name(s), given name(s) and full

address(es) of the inventor(s) in accordance

with Rule 19(1) EPC.

3 If the applicant is not the inventor or is not the

sole inventor, the designation shall contain a

statement indicating the origin of the right to

the European patent (Article 81, Rule 19(1)

EPC).

In the case of assignment the words

”by agreement dated ...” suf ce.

In the case of inventions by employees a

mention that the inventor(s) is/are employee(s)

of the applicant(s) is suf cient.

In the case of succession a mention that the

applicant(s) is/are heir(s) of the inventor(s) is

suf cient.

PCT Applicant’s Guide – National Phase – National Chapter – EP Annex EP.IV, page 1

(30 May 2013)







 

 





  



 

   























 

 



 





 

 



 





















9ROOPDFKW

$XWKRULVDWLRQ

3RXYRLU









111







 



Annex EP.IV, page 2 PCT Applicant’s Guide – National Phase – National Chapter – EP

(30 May 2013)

, )XQRWHQ]XU9RUGHUVHLWH

  















  





  













  











  

 































 





 

 



 



 

 



















 

















,, +LQZHLVH

  







  













  







  





,  5HQYRLVFRQFHUQDQWOHWH[WH

¿JXUDQWDXUHFWR

  















































  

 















 













 





 





 



 





















 















,,1RWHV

  







  











  







  







, )RRWQRWHVWRWH[WRYHUOHDI

  



  







  

  

  



  





  















  

  

  

  

 

























 

 

 





 



 



 





































,,1RWLFHV

  





  

  









  









  





11.11

PCT Applicant’s Guide – National Phase – National Chapter – EP Annex EP.V, page 1

(30 May 2013)

General authorisation

EPO 1004 09.11

I (We)

Full name and address of authorisor(s)

Please forward the original direct to the EPO,

Legal Division (Dir. 5.2.3) in Munich.

Please read the attached notes before

completing the form.

General

authorisation No.



 

Place, Date Signature*

do hereby authorise

Full name and address

of authorisee: professional

representative, legal practitioner,



representatives – please specify

to represent me (us) in all proceedings established by the European Patent Convention and to act for me (us) in all patent

transactions.



!"

#$!

%

!

* The form must bear the personal signature(s) of the authorisor(s). In the case of legal persons, the signature

 !&!

Annex EP.V, page 2 PCT Applicant’s Guide – National Phase – National Chapter – EP

(30 May 2013)

EPO 1004 09.11

Notes

to the General authorisation Form (EPO 1004)

The use of this form is recommended when authorising repre sen-

'*'*+professional

representatives and legal practitioners under Article 134(8)

'"/employees%6777'"

associations of representatives;6<=66'"%

%6777'"!!

has been issued up to the present time. If the authorisee is an

!

practitioner, the authorisor must make a declaration in the general

authorisation or in a covering letter that the authorisee is his



!!

(hereafter “authorisor”) and the state in which their residence or

principal place of business is located must be given, in accordance

;>6=+

?@

!!

as well as of bodies equivalent to legal persons under the law

!!!

Addresses shall be indicated in accordance with applicable

B

comprise all the relevant administrative units, including the house

C

H!!

relevant information regarding the additional authorisors must be

!

Where there are several authorisors, a general authorisation can



If one of several authorisors cancels a general authorisation,

it remains valid for the other authorisors under the old registration

B!

registered.

The name(s) and address of the place of business of the

authorisee(s) must be given in accordance with Rule 41(2)(c)

=

!

of representatives. As regards the authorisation of an association

!;6<=66'"

the name and the number of the association must be given.

If there is more than one authorisee, please insert in the

address box the name and address of the place of business of

the authorisee to whom the EPO is to send a copy of the form

bearing the general authorisation number.

A communication regarding the registration of the general

authorisation is not !

for which the authorisee is or is to be appointed as representative.

J

authorisations in a general authorisation. When a general

authorisation is intended to supersede an earlier one, the earlier

@

The general authorisation of one or more authorisees terminates

as soon as the authorisor or the authorisee concerned –

not another authorisee – has communicated the termination to

the EPO in Munich (Directorate 5.2.3). The communication

!&

new general authorisation omitting the name of the authorisee

;6<=KQ'"

The powers

"!!$

!!!



!

'"!!

sub-authorisations%6777;6<='"

be it

(a) a  (Rule 152(2), second sentence,

 '"

(b) a general sub-authorisation;6<=>'"

When issuing a general sub-authorisation, Form EPO 1004 can for

$!

authorisation number from which he derives his power. When it is

registered, the general sub-authorisation keeps the same number

!!

#U

general sub-authorisation does not terminate vis-à-vis the EPO

!;6<=V'"

upon the termination of the authorisation given to the sub-authorisor



'*!

>

&'*

(see 3 above).

Where the authorisation is signed on behalf of a legal person,

only such persons as are entitled to sign by law and/or in

accordance with the articles of association or equivalent of

the legal person may do so %<Q'"

%!!@!

!/XYZ

J[!$Y!/\\

&!!

!



An authorisation bearing the

signature of a person not entitled to sign will be treated as an

unsigned authorisation.

Product Detail Manual EP

Navigation menu

Versions of this User Manual:

Views

Navigation